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FIELD OF THE INVENTION
[0001] The present invention relates to the use of a nucleic acid sequence for the generation of transgenic plants
having enhanced drought tolerance, and to a method for the generation of transgenic plants with enhanced drought
tolerance.
BACKGROUND OF THE INVENTION
[0002] Plants are constantly challenged by environmental stress factors that affect their survival. Adverse biotic and
abiotic stress factors can reduce the growth and productivity of plant crops. As tolerance to biotic and abiotic stresses
has a direct impact on plant productivity (yield and product quality), mechanisms for conferring or enhancing stress
tolerance have been widely studied and various approaches for conferring environmental stress tolerance have been
described in the art. However, while most studied mechanisms are on either biotic or abiotic stress interactions, in nature
plants respond and resist multiple stress factors.
[0003] Environmental stress factors have been estimated to cause depreciation in crop yield up to 70% when compared
to the yield under favorable conditions (Boyer, Science 218, 443-448, 1982). Stability of crops to changes in environmental
factors are therefore one of the most valued traits for breeding. However, traditional breeding is thwarted by the complexity
of stress tolerance traits, low genetic variance of yield components and the lack of efficient selection techniques. It might
therefore be useful to follow specific genes coding for stress tolerance components, in breeding by marker-assisted
selection as well as by genetically engineering plants to be more stress tolerant.
[0004] Amidst the complexities of environmental stress reactions in crop plants the use of the simple model Arabidopsis,
offers an opportunity for the precise genetic analysis of stress reaction pathways common to most plants. The relevance
of the Arabidopsis model is evident in recent examples of improving drought, salt and freezing tolerance (Jaglo-Ottosen
et al., Science 280, 104-106, 1998; Kasuga et al., Nat. Biotechnol. 17, 287-291, 1999) using genes identified in Arabi-
dopsis. These genes are transcription factors of the ERF/AP2 family that regulate the expression of a number of down-
stream genes conferring stress resistance in a number of heterologous plants.
[0005] One of the most serious abiotic stresses plants have to cope with world-wide is drought stress or dehydration
stress. Four-tenths of the world’s agricultural land lies in arid or semi-arid regions. Apart from that, also plants grown in
regions with relatively high precipitation may suffer spells of drought throughout the growing season. Many agricultural
regions, especially in developing countries, have consistently low rain-fall and rely on irrigation to maintain yields. Water
is scarce in many regions and its value will undoubtedly increase with global warming, resulting in an even greater need
for drought tolerant crop plants, which maintain yield levels (or even have higher yields) and yield quality under low water
availability. It has been estimated that the production of 1 kg of cotton requires about 15,000 litres of water in irrigated
agriculture, while 1 kg of rice requires 4000 litres. Enhancing or engineering the tolerance of crop plants to short and
long spells of drought and reducing the water requirement of crops grown in irrigated agriculture is clearly an important
objective.
[0006] Although breeding (e.g. marker assisted) for drought tolerance is possible and is being pursued for a range of
crop species (mainly cereals, such as maize, upland rice, wheat, sorghum, pearl millet, but also in other species such
as cowpea, pigeon pea and Phaseolus bean), it is extremely difficult and tedious because drought tolerance or resistance
is a complex trait, determined by the interaction of many loci and gene- environment interactions. Single, dominant
genes, which confer or improve drought tolerance and which can be easily transferred into high yielding crop varieties
and breeding lines are therefore sought after. Most water is lost through the leaves, by transpiration, and many transgenic
approaches have focused on modifying the water loss through changing the leaves. For example WO00/73475 describes
the expression of a C4 NADP+-malic enzyme from maize in tobacco epidermal cells and guard cells, which, according
to the disclosure, increases water use efficiency of the plant by modulating stomatal aperture. Other approaches involve,
for example, the expression of osmo-protectants, such as sugars (e.g. trehalose biosynthetic enzymes) in plants in order
to increase water-stress tolerance, see e.g. WO99/46370. Yet other approaches have focused on changing the root
architecture of plants.
[0007] To date another promising approach to enhance drought tolerance is the overexpression of CBF/DREB genes
(DREB refers to dehydration response element binding; DRE binding), encoding various AP2/ERF (ethylene response
factor) transcription factors (WO98/09521). Overexpression of the CBF/DREB1 proteins in Arabidopsis resulted in an
increase in freezing tolerance (also referred to as freeze-induced dehydration tolerance) (Jaglo-Ottosen et al., Science
280, 104-106, 1998; Liu et al., Plant Cell 10, 1391-1406, 1998; Kasuga et al., Nat. Biotechnol. 17, 287-291, 1999; Gilmour
et al. Plant Physiol. 124, 1854-1865, 2000) and enhanced the tolerance of the recombinant plants to dehydration caused
either by water deficiency or exposure to high salinity’ (Liu et al., 1998, supra; Kasuga et al., 1999, supra). Another CBF
transcription factor, CBF4, has been described to be a regulator of drought adaptation in Arabidopsis (Haake et al. 2002,













Plant Physiology 130, 639-648).
[0008] WO 2004/031349 describes a transcription factor designated G1753, having the sequence of SEQ ID NO: 3
as disclosed hereinafter. This reference also describes transgenic crop plants comprising a nucleic acid sequence
encoding a protein having the sequence of SEQ ID NO: 3. According to this reference G1753 can be used to create
dwarf forms of ornamental plants and to alter the sugar signaling in plants.
[0009] Despite the availability of some genes which have been shown to enhance drought tolerance in a number of
plant species, such as Brassicaceae and Solanaceae, there is a need for the identification of other genes with the ability
to confer or improve drought tolerance when expressed in crop plants. In one embodiment, the present invention provides
the use of a gene for the generation of transgenic plants having a combination of two or more of the following phenotypes:
enhanced drought tolerance, enhanced disease resistance and enhanced root structure.
[0010] Biotic stresses like pathogen (bacteria, fungi, virus) or pests (insect, nematode) are the most common and a
number of mechanisms normally protect plants against most of these threats. However, in certain cases plants display
a susceptible reaction to specific pathogens or pests and are considered as host for the particular pathogen or pest.
The host-pathogen interaction has been well characterized by the gene-for-gene concept where specific genes from the
host plant and a pathogen/pest interact to either display a susceptible or a resistant reaction. Though the molecular
genetics of such interactions have been well characterized in recent years, the use of such simple resistance genes has
been hampered by the versatile mutability of the pathogen system that produces the diversity to overcome the resistance
genes. In general the resistance genes belong to a few general classes of proteins that comprise of leucine rich repeats
and additional domains. Though these genes and genetic interactions are interesting to study plant pathogen interactions,
their employment for crop protection against a wider diversity and range of pathogens is still a ways away. Another way
that can provide resistance is to use genes that are involved in the protection of plants to a diverse range of pathogens
using mechanisms that do not rely on recognition of plant and pathogens. This would confer a non race specific resistance
which is broader as it would confer resistance to a wider range of pathogens.
GENERAL DEFINITIONS
[0011] The term "nucleic acid sequence" (or nucleic acid molecule) refers to a DNA or RNA molecule in single or
double stranded form, particularly a DNA encoding a protein or protein fragment according to the invention. An "isolated
nucleic acid sequence" refers to a nucleic acid sequence which is no longer in the natural environment from which it
was isolated, e.g. the nucleic acid sequence in a bacterial host cell or in the plant nuclear or plastid genome.
[0012] The terms "protein" or "polypeptide" are used interchangeably and refer to molecules consisting of a chain of
amino acids, without reference to a specific mode of action, size, threedimensional structure or origin. A "fragment" or
"portion" of a protein may thus still be referred to as a "protein". An "isolated protein" is used to refer to a protein which
is no longer in its natural environment, for example in vitro or in a recombinant bacterial or plant host cell.
[0013] The term "gene" means a DNA sequence comprising a region (transcribed region), which is transcribed into
an RNA molecule (e.g. an mRNA) in a cell, operably linked to suitable regulatory regions (e.g. a promoter). A gene may
thus comprise several operably linked sequences, such as a promoter, a 5’ leader sequence comprising e.g. sequences
involved in translation initiation, a (protein) coding region (cDNA or genomic DNA) and a 3’non-translated sequence
comprising e.g. transcription termination sites.
[0014] A "chimeric gene" (or recombinant gene) refers to any gene, which is not normally found in nature in a species,
in particular a gene in which one or more parts of the nucleic acid sequence are present that are not associated with
each other in nature. For example the promoter is not associated in nature with part or all of the transcribed region or
with another regulatory region. The term "chimeric gene" is understood to include expression constructs in which a
promoter or transcription regulatory sequence is operably linked to one or more coding sequences or to an antisense
(reverse complement of the sense strand) or inverted repeat sequence (sense and antisense, whereby the RNA transcript
forms double stranded RNA upon transcription).
[0015] "Expression of a gene" refers to the process wherein a DNA region, which is operably linked to appropriate
regulatory regions, particularly a promoter, is transcribed into an RNA, which is biologically active, i.e. which is capable
of being translated into a biologically active protein or peptide (or active peptide fragment) or which is active itself (e.g.
in posttranscriptional gene silencing or RNAi). An active protein in certain embodiments refers to a protein having a
dominant-negative function due to a repressor domain being present. The coding sequence is preferably in sense-
orientation and encodes a desired, biologically active protein or peptide, or an active peptide fragment. In gene silencing
approaches, the DNA sequence is preferably present in the form of an antisense DNA or an inverted repeat DNA,
comprising a short sequence of the target gene in antisense or in sense and antisense orientation. "Ectopic expression"
refers to expression in a tissue in which the gene is normally not expressed.
[0016] A "transcription regulatory sequence" is herein defined as a nucleic acid sequence that is capable of regulating
the rate of transcription of a (coding) sequence operably linked to the transcription regulatory sequence. A transcription
regulatory sequence as herein defined will thus comprise all of the sequence elements necessary for initiation of tran-













scription (promoter elements), for maintaining and for regulating transcription, including e.g. attenuators or enhancers.
’ Although mostly the upstream (5’) transcription regulatory sequences of a coding sequence are referred to, regulatory
sequences found downstream (3’) of a coding sequence are also encompassed by this definition.
[0017] As used herein, the term "promoter" refers to a nucleic acid fragment that functions to control the transcription
of one or more genes, located upstream with respect to the direction of transcription of the transcription initiation site of
the gene, and is structurally identified by the presence of a binding site for DNA-dependent RNA polymerase, transcription
initiation sites and any other DNA sequences, including, but not limited to transcription factor binding sites, repressor
and activator protein binding sites, and any other sequences of nucleotides known to one of skill in the art to act directly
or indirectly to regulate the amount of transcription from the promoter. A "constitutive" promoter is a promoter that is
active in most tissues under most physiological and developmental conditions. An "inducible" promoter is a promoter
that is physiologically (e.g. by external application of certain compounds) or developmentally regulated. A "tissue specific"
promoter is only active in specific types of tissues or cells.
[0018] As used herein, the term "operably linked" refers to a linkage of polynucleotide elements in a functional rela-
tionship. A nucleic acid is "operably linked" when it is placed into a functional relationship with another nucleic acid
sequence. For instance, a promoter, or rather a transcription regulatory sequence, is operably linked to a coding sequence
if it affects the transcription of the coding sequence. Operably linked means that the DNA sequences being linked are
typically contiguous and, where necessary to join two protein encoding regions, contiguous and in reading frame so as
to produce a "chimeric protein". A "chimeric protein" or "hybrid protein" is a protein composed of various protein "domains"
(or motifs) which is not found as such in nature but which a joined to form a functional protein, which displays the
functionality of the joined domains (for example DNA binding or repression leading to a dominant negative function). A
chimeric protein may also be a fusion protein of two or more proteins occurring in nature. The term "domain" as used
herein means any part(s) or domain(s) of the protein with a specific structure or function that can be transferred to another
protein for providing a new hybrid protein with at least the functional characteristic of the domain. Specific domains can
also be used to identify protein members belonging to a group of similar transcription factors, such as orthologs from
other plant species.
[0019] The term "target peptide" refers to amino acid sequences which target a protein to intracellular organelles such
as plastids, preferably chloroplasts, mitochondria, or to the extracellular space (secretion signal peptide). A nucleic acid
sequence encoding a target peptide may be fused (in frame) to the nucleic acid sequence encoding the amino terminal
end (N-terminal end) of the protein.
[0020] A "nucleic acid construct" or "vector" is herein understood to mean a man-made nucleic acid molecule resulting
from the use of recombinant DNA technology and which is used to deliver exogenous DNA into a host cell. The vector
backbone may for example be a binary or superbinary vector (see e.g. US5591616, US2002138879 and WO9506722),
a co-integrate vector or a T-DNA vector, as known in the art and as described elsewhere herein, into which a chimeric
gene is integrated or, if a suitable transcription regulatory sequence is already present, only a desired nucleic acid
sequence (e.g. a coding sequence, an antisense or an inverted repeat sequence) is integrated downstream of the
transcription regulatory sequence. Vectors usually comprise further genetic elements to facilitate their use in molecular
cloning, such as e.g. selectable markers, multiple cloning sites and the like (see below).
[0021] A "host cell" or a "recombinant host cell" or "transformed cell" are terms referring to a new individual cell (or
organism) arising as a result of at least one nucleic acid molecule, especially comprising a "chimeric gene encoding a
desired protein or a nucleic acid sequence which upon-transcription yields an antisense RNA or an inverted repeat RNA
(or hairpin RNA) for silencing of a target gene/gene family, having been introduced into said cell. The host cell is preferably
a plant cell or a bacterial cell. The host cell may contain the nucleic acid construct as an extra-chromosomally (episomal)
replicating molecule, or more preferably, comprises the chimeric gene integrated in the nuclear or plastid genome of the
host cell.
[0022] The term "selectable marker" is a term familiar to one of ordinary skill in the art and is used herein to describe
any genetic entity which, when expressed, can be used to select for a cell or cells containing the selectable marker.
Selectable marker gene products confer for example antibiotic resistance, or more preferably, herbicide resistance or
another selectable trait such as a phenotypic trait (e.g. a change in pigmentation) or nutritional requirements. The term
"reporter" is mainly used to refer to visible markers, such as green fluorescent protein (GFP), eGFP, luciferase, GUS
and the like.
[0023] The term "ortholog" of a gene or protein refers herein to the homologous gene or protein found in another
species, which has the same function as the gene or protein, but (usually) diverged in sequence from the time point on
when the species harbouring the genes diverged (i.e. the genes evolved from a common ancestor by speciation).
Orthologs of an Arabidopsis gene may thus be identified in other plant species based on both sequence comparisons
(e.g. based on percentages sequence identity over the entire sequence or over specific domains) and functional analysis.
[0024] The terms "homologous" and "heterologous" refer to the relationship between a nucleic acid or amino acid
sequence and its host cell or organism, especially in the context of transgenic organisms. A homologous sequence is
thus naturally found in the host species (e.g. a tomato plant transformed with a tomato gene), while a heterologous













sequence is not naturally found in the host cell (e.g. a tomato plant transformed with a sequence from potato plants).
Depending on the context, the term "homolog" or "homologous" may alternatively refer to sequences which are descend-
ent from a common ancestral sequence (e.g. they may be orthologs).
[0025] "Stringent hybridisation conditions" can be used to identify nucleotide sequences, which are substantially iden-
tical to a given nucleotide sequence. Stringent conditions are sequence dependent and will be different in different
circumstances. Generally, stringent conditions are selected to be about 5°C lower than the thermal melting point (Tm)
for the specific sequences at a defined ionic strength and pH. The Tm is the temperature (under defined ionic strength
and pH) at which 50% of the target sequence hybridises to a perfectly matched probe. Typically stringent conditions will
be chosen in which the salt concentration is about 0.02 molar at pH 7 and the temperature is at least 60°C. Lowering
the salt concentration and/or increasing the temperature increases stringency. Stringent conditions for RNA-DNA hy-
bridisations (Northern blots using a probe of e.g. 100nt) are for example those which include at least one wash in 0.2X
SSC at 63°C for 20min, or equivalent conditions. Stringent conditions for DNA-DNA hybridisation (Southern blots using
a probe of e.g. 100nt) are for example those which include at least one wash (usually 2) in 0.2X SSC at a temperature
of at least 50°C, usually about 55°C, for 20 min, or equivalent conditions. See also Sambrook et al. (1989) and Sambrook
and Russell (2001).
[0026] "Sequence identity" and "sequence similarity" can be determined by alignment of two peptide or two nucleotide
sequences using global or local alignment algorithms. Sequences may then be referred to as "substantially identical" or
"essentially similar" when they (when optimally aligned by for example the programs GAP or BESTFIT using default
parameters) share at least a certain minimal percentage of sequence identity (as defined below). GAP uses the Needle-
man and Wunsch global alignment algorithm to align two sequences over their entire length, maximizing the number of
matches and minimises the number of gaps. Generally, the GAP default parameters are used, with a gap creation penalty
= 50 (nucleotides) / 8 (proteins) and gap extension penalty = 3 (nucleotides) / 2 (proteins). For nucleotides the default
scoring matrix used is nwsgapdna and for proteins the default scoring matrix is Blosum62 (Henikoff & Henikoff, 1992,
PNAS 89, 915-919). Sequence alignments and scores for percentage sequence identity may be determined using
computer programs, such as the GCG Wisconsin Package, Version 10.3, available from Accelrys Inc., 9685 Scranton
Road, San Diego, CA 92121-3752 USA. Alternatively percent similarity or identity may be determined by searching
against databases such as FASTA, BLAST, etc.
[0027] In this document and in its claims, the verb "to comprise" and its conjugations is used in its non-limiting sense
to mean that items following the word are included, but items not specifically mentioned are not excluded. In addition,
reference to an element by the indefinite article "a" or "an" does not exclude the possibility that more than one of the
element is present, unless the context clearly requires that there be one and only one of the elements. The indefinite
article "a" or "an" thus usually means "at least one". It is further understood that, when referring to "sequences" herein,
generally the actual physical molecules with a certain sequence of subunits (e.g. amino acids) are referred to.
DETAILED DESCRIPTION OF THE INVENTION
[0028] Using activation tagging, the inventors isolated and characterized an Arabidopsis gene, referred to as HARDY
(HRD), the overexpression of which resulted in a number of changes in plant architecture and associated internal
structures compared to the wild type. The activation of HRD resulted in leaves that are thicker in appearance, with a
smaller compact hardy plant structure. The plant is more difficult to pull out of the ground, probably due to the enhanced
lateral root network. The HRD gene was cloned and sequenced and was found to be similar to transcriptional factors
defined as AP2/ERF (Alonso et al. 2003, Science 301, 653-657). However no functions of HRD have been described
and no uses for the HRD gene suggested in the art.
[0029] Constitutive expression of the HRD gene in transgenic Arabidopsis plants showed the same phenotype as the
original activation tag line, although the phenotype was more severe. The original overexpression mutant hrd was tested
for resistance to abiotic and biotic stress conditions and was found to be significantly more resistant than wild-type
controls. In addition a conditional overexpression strategy, using a HRD fusion to a glucorticoid receptor, showed the
phenotype can be induced and plants with mild or almost no phenotype were resistant to the stress tests. Microarray
experiments of the hrd mutant, using whole genome Arabidopsis microarrays, showed differential expression of a set
of genes that were different from that of overexpression of the other known stress resistant AP2/ERF genes like DREB1A,
indicating a different mechanism in conferring general stress resistance.
Nucleic acid sequences and proteins used in the invention
[0030] In the invention nucleic acid sequences and amino acid sequences of members of the HARDY transcription
factor are used.
[0031] The function of a protein can be tested using a variety of known methods, preferably by comparing the phenotype
of transformants constitutively expressing the protein being tested to the phenotype of HRD over-expressing transform-













ants of the same host species (and variety) (preferably comprising a chimeric HRD encoding gene stably integrated into
the host’s genome), allowing a direct comparison of the functional effect on the phenotype of the transformants. It is
understood that in any transformation experiments a certain degree of variation in the phenotype of transformants is
seen, normally due to position effects in the genome and/or due to copy number. A skilled person will know how to
compare transformants to one another, e.g. by selecting single copy number events and analysing their phenotypes.
Other methods of determining or confirming in vivo gene/protein function include the generation of knock-out mutants
or transient expression studies. Promoter-reporter gene expression studies may also provide information as to the spatio-
temporal expression pattern and the role of the protein.
[0032] Constitutive (over) expression of the HARDY gene member results in one or more of the following phenotypic
changes compared to the wild type or control transformants:
- Thicker leaves with an increased layer mesophyll layer
- Smaller compact and hardy looking plant
- Stronger root structure with enhanced lateral roots
- Increased resistance to a pathogen, e.g. non-race specific (Verticillium)
- Enhanced tolerance to drought as revealed by higher survival than wild-type
[0033] These phenotypes can be utilized in creating transgenic plants or plant tissues/organs with modified and im-
proved agronomical characteristics, such as enhanced drought tolerance and others as described elsewhere herein.
[0034] The invention provides the use of a nucleic acid sequence encoding a protein having the sequence of SEQ ID
NO: 3 or a protein at least 70 % identical to SEQ ID NO: 3, or an ortholog protein for the generation of transgenic plants
having a combination of two or more of the phenotypes selected from the group consisting of: enhanced drought tolerance,
enhanced disease resistance and enhanced root structure.
[0035] Further the invention provides a method for the generation of transgenic plants having a combination of two
or more of the phenotypes selected from the group consisting of: enhanced drought tolerance, enhanced disease
resistance and enhanced root structure, comprising inserting in the genome of the plant a chimeric gene comprising a
transcription regulatory sequence active in plant cells operably linked to a nucleic acid sequence encoding a protein
having the sequence of SEQ ID NO:3 or a protein at least 70% identical to SEQ ID NO:3, or an ortholog protein.
[0036] In a preferred embodiment said transcription regulatory sequence is selected from the group consisting of: a
constitutive promoter, an inducible promoter, a tissue-specific promoter and a developmentally regulated promoter.
[0037] Further it is preferred that the transcription regulatory sequence is a stress inducible promoter.
[0038] Preferably the encoding nucleic acid sequence used in this invention has the sequence of SEQ ID NO: 1.
[0039] Other members similar to HARDY can be identified in silico, e.g. by identifying nucleic acid or protein sequences
in existing nucleic acid or protein database (e.g. GENBANK, SWISSPROT, TrEMBL) and using standard sequence
analysis software, such as sequence similarity search tools (BLASTN, BLASTP, BLASTX, TBLAST, FASTA, etc.).
[0040] The HRD proteins used in the invention, example provided as SEQ ID NO: 3, may be isolated from natural
sources, synthesized de novo by chemical synthesis (using e.g. a peptide synthesizer such as supplied by Applied
Biosystems) or produced by recombinant host cells. The HRD proteins used in the invention may be used to raise mono-
or polyclonal antibodies, which may for example be used for the detection of HRD proteins in samples (immunochemical
analysis methods and kits).
[0041] Chimeric or hybrid HRD proteins comprise segments of the AP2 domain and other parts of the HRD protein.
Domains may be exchanged (domain swapping) between HRD proteins and other unrelated proteins, as long as the
functionality of the resulting chimeric protein is essentially similar to that of HRD. A chimeric HRD protein may thus, for
example, comprise the HRD protein, including the AP2 domain and in addition one or more protein domains not normally
found in HRD proteins, such as stabilizing domains, binding domains (e.g. hormone binding domains, such as found in
the glucocorticoid receptor, resulting in inducibility), etc. In another embodiment chimeric HRD proteins are provided
which comprise a HRD-repressor domain fusion, such as the HRD-EAR fusion described below. In transgenic plants,
overexpression of these chimeric proteins result in a dominant negative phenotype. HRD-repressor domain fusion may
also comprise additional domains fused thereto, such as e.g. a hormone binding domain (see e.g. Markel et al. 2002,
Nucl. Acid Res. 30, 4709-4719).
[0042] Also used are nucleic acid sequences (genomic DNA, cDNA, RNA) encoding HRD protein, such as for example
HRD, as defined above (including any chimeric or hybrid HRD proteins), or any HRD protein from another species. Due
to the degeneracy of the genetic code various nucleic acid sequences may encode the same amino acid sequence. The
nucleic acid sequences provided include naturally occurring, artificial or synthetic nucleic acid sequences. Example of
nucleic acid sequence encoding HRD is provided for in SEQ ID NO: 1 (sequence coding for HRD protein from Arabidopsis)
and SEQ ID NO: 2 (genomic HRD sequence from Arabidopsis). It is understood that when sequences are depicted in
as DNA sequences while RNA is referred to, the actual base sequences of the RNA molecule is identical witch the
difference that thymine (T) is replace by uracil (U).













[0043] It is clear that many methods can be used to identify,’ synthesise or isolate variants or fragments of HRD nucleic
acid sequences, such as nucleic acid hybridization, PCR technology, in silico analysis and nucleic acid synthesis, and
the like.
[0044] The nucleic acid sequence, particularly DNA sequence, encoding the HRD proteins used in this invention can
be inserted in expression vectors to produce high amounts of HRD proteins (or e.g. chimeric HRD proteins)., as described
below. For optimal expression in a host the HRD DNA sequences can be codon-optimized by adapting the codon usage
to that most preferred in plant genes, particularly to genes native to the plant genus or species of interest (Bennetzen
& Hall, 1982, J. Biol. Chem. 257, 3026-3031; Itakura et al., 1977 Science 198, 1056-1063.) using available codon usage
tables (e. g. more adapted towards expression in cotton, soybean corn or rice). Codon usage tables for various plant
species are published for example by Ikemura (1993, In "Plant Molecular Biology Labfax", Croy, ed., Bios Scientific
Publishers Ltd.) and Nakamura et al. (2000, Nucl. Acids Res. 28, 292.) and in the major DNA sequence databases (e.g.
EMBL at Heidelberg, Germany). Accordingly, synthetic DNA sequences can be constructed so that the same or sub-
stantially the same proteins are produced. Several techniques for modifying the codon usage to that preferred by the
host cells can be found in patent and scientific literature. The exact method of codon usage modification is not critical
for this invention.
[0045] Small modifications to a DNA sequence such as described above can be routinely made, i.e., by PCR-mediated
mutagenesis (Ho et al., 1989, Gene 77, 51-59., White et al., 1989, Trends in Genet. 5, 185-189). More profound modi-
fications to a DNA sequence can be routinely done by de novo DNA synthesis of a desired coding region using available
techniques.
[0046] Also, the HRD nucleic acid sequences can be modified so that the N-terminus of the HRD protein has an
optimum translation initiation context, by adding or deleting one or more amino acids at the N-terminal end of the protein.
Often it is preferred that the proteins used in the invention to be expressed in plants cells start with a Met-Asp or Met-
Ala dipeptide for optimal translation initiation. An Asp or Ala codon may thus be inserted following the existing Met, or
the second codon, Val, can be replaced by a codon for Asp (GAT or GAC) or Ala (GCT, GCC, GCA or GCG). The DNA
sequences may also be modified to remove illegitimate splice sites.
[0047] In one embodiment of the invention HRD gene expression is downregulated in a host cell, plant or specific
tissue(s), by e.g. RNAi approaches, as described elsewhere. In yet another embodiment HRD loss-of-function phenotypes
(of host cells, tissues or whole plants) are generated by expressing a nucleic acid sequence encoding a protein fusion
of a HRD protein (as defined) with a (dominant) repressor domain. "Loss-of-function" refers herein to the loss of HRD
protein function in a host tissue or organisms, and encompasses the function at the molecular level (e.g. loss of tran-
scriptional activation of downstream target genes of the HRD transcription factor) and preferably also at the phenotypic
level. For example, in order to provide loss-of-function, HRD protein fusions are made with a 12 amino acid ’EAR’
repressor domain as described by Hiratsu et al., 2003 (Plant J. 34:733-739). These repressor domain fusions to any
one of the HRD proteins (as defined), termed herein ’HRD-EAR’ fusion proteins, are able to cause repression of the
downstream target genes and thus result in an effective loss-of-function mutant (dominant negative effect). These
repressor fusions also effect repression in heterologous plants where the orthologous genes have not yet been identified.
In one embodiment a nucleic acid sequence is provided which encodes a chimeric repressor domain-HRD protein fusion
protein, especially a HRD-EAR fusion protein. In addition a vector comprising said nucleic acid sequence and a host
cell, tissue and/or organism comprising the chimeric gene is provided. To generate a HRD-repressor domain fusion
protein, the nucleic acid sequence encoding the repressor domain is translationally fused to the nucleic acid sequence
comprising the HRD coding sequence. The HRD-repressor domain fusion protein encoding nucleic acid sequence
(especially HRD-EAR) is placed under control of constitutive or specific promoters (e.g. tissue specific or developmentally
regulated). Constitutive expression provides a loss-of-function in all host tissues where HRD or orthologs are expressed
and required for function. Specific expression of the HRD-EAR protein provides a loss-of-function in the specific tissue
or condition, e.g. when a specific promoter is operably linked to a nucleic acid encoding a HRD-EAR fusion protein.
[0048] It is understood that HRD proteins may be operably fused to other repression domains available in the art which
function in plant cells. These include repressor domains of animal proteins, such as the Drosophila ENGRAILED (En)
repressor domain. For example the N-terminal 298 amino acids may be fused to a HRD protein according to the invention,
creating a dominant-negative chimeric protein (see Markel et al. 2002, Nucleic Acid Research Vol 30, 4709-4719 and
Chandler and Werr 2003, Trends in Plant Science Vol. 8, 279-285). It is noted that repressor domains may be fused to
the HRD protein at the C-terminus or at the N-terminus, depending on the domain. The nucleic acid sequence encoding
the dominant-negative fusion protein may be referred to as a "dominant-negative chimeric gene" and when transferred
into a host genome as a "dominant-negative transgener" (either stably integrated in the host genome or transiently
expressed). Other plant repressor domains are for example the LEUNG and SEUSS co-repressors of AGAMOUS, FLC
and polycomb proteins. Other animal repressor domains include for example the WT1, eve, c-ErbA and v-ErbA and
Krüppel associated box (see Chandler and Werr, 2003, supra and references therein).
[0049] PCR primers and/or probes and kits for detecting the HRD DNA sequences can be used. Degenerate or specific
PCR primer pairs to amplify HRD DNA from samples can be synthesized based on SEQ ID NO 3 as known in the art













(see Dieffenbach and Dvek-sler (1995) PCR Primer: A Laboratory Manual, Cold Spring Harbor Laboratory Press, and
McPherson at al. (2000) PCR-Basics: From Background to Bench, First Edition, Springer Verlag, Germany). Likewise,
DNA fragments of SEQ ID NO’s 1-2 can be used as hybridization probes. An HRD detection kit may comprise either
HRD specific primers and/or HRD specific probes, and an associated protocol to use the primers or probe to detect
HRD DNA in a sample. Such a detection kit may, for example, be used to determine, whether a plant has been transformed
with an HRD gene (or part thereof) of the invention. Because of the degeneracy of the genetic code, some amino acid
codons can be replaced by others without changing the amino acid sequence of the protein.
[0050] Antibodies that bind specifically to a HRD protein used in the invention can be used . In particular monoclonal
or polyclonal antibodies that bind to HRD or to fragments or variants thereof, are encompassed herein. An antibody can
be prepared by using a HRD protein used in the invention as an antigen in an animal using methods known in the art,
as e.g. described in Harlow and Lane "Using Antibodies: A laboratory manual"(New York: Cold Spring Harbor Press
1998) and in Lid-dell and Cryer "A Practical Guide to Monoclonal Antibodies" (Wiley and Sons, 1991). The antibodies
can subsequenctly be used to isolate, identify, characterize or purify the HRD protein to which it binds, for example to
detect the HRD protein in a sample, allowing the formation of an immunocomplex and detecting the presence of the
immunocomplex by e.g. ELISA (enzyme linked immunoassay) or immunoblot analysis. Also use can be made of immu-
nological kits, useful for detecting the HRD proteins’, protein fragments or epitopes in a sample. Samples may be cells,
cell supernatants, cell suspensions, tissues, etc. Such a kit comprises at least an antibody that binds to a HRD protein
and one or more immunodetection reagents. The antibodies can also be used to isolate/identify other HRD proteins, for
example by ELISA or Western blotting.
[0051] In addition, nucleic acid sequences comprising the HRD promoter can be used herein. The transcription reg-
ulatory sequences are found in the about 1 kb sequence upstream of the ATG codon of SEQ ID NO: 1. The transcription
regulatory sequence of HRD is provided herein in SEQ ID NO: 2, as the 5’ region of 1.1 kb. These transcription regulatory
sequences may be used for the construction of chimeric genes and for expressing operably linked nucleic acid sequences
in hosts or host cells. Especially the HRD transcription regulatory sequence may be used for expression in seed and
embryo for expression of genes for early stress tolerance. It is understood that the tissue specificity of the transcription
regulatory sequences can be improved or specified by analysing deletion fragments of the sequences provided for their
ability to direct expression of nucleic acid sequences operably linked thereto. Such deletion analysis allows the removal
of nucleic acid parts which cause non-specific (background) expression. Similarly, the transcription regulatory sequences
of other HRD-like genes can be isolated by sequencing the genomic DNA upstream of the ATG codon, using known
methods such as TAIL-FCR.
Chimeric genes, vectors and recombinant microorganisms used in the invention
[0052] In the invention nucleic acid sequences encoding HRD proteins (including e.g. fusion proteins such as HRD-
GR and HRD-EAR), as described above, are used to make chimeric genes, and vectors comprising these for transfer
of the chimeric gene into a host cell and production of the HRD protein (s) in host cells, such as cells, tissues, organs
or organisms derived from transformed cell(s). Host cells are preferably plant cells, but microbial hosts (bacteria, yeast,
fungi, etc.) are also envisaged. Any crop plant may be a suitable host, such as monocotyledonous plants or dicotyledonous
plants, for example maize/corn (Zea species, e.g. Z. mays, Z. diploperennis (chapule), Zea luxurians (Guatemalan
teosinte), Zea mays subsp. huehuetenangensis (San Antonio Huista teosinte), Z. mays subsp. mexicana (Mexican
teosinte), Z. mays subsp. parviglumis (Balsas teosinte), Z. perennis (perennial teosinte) and Z. ramosa), wheat (Triticum
species), barley (e.g. Hordeum vulgare), oat (e.g. Avena sativa), sorghum (Sorghum bicolor), rye (Secale cereale),
soybean (Glycine spp, e.g. G. max), cotton (Gossypium species, e.g. G. hirsutum, G. barbadense), Brassica spp. (e.g.
B. napus, B. j uncea, B. oleracea, B. rapa, etc), sunflower (Helianthus annus), tobacco (Nicotiana species), alfalfa
(Medicago sativa), rice (Oryza species, e.g. O. sativa indica cultivar-group or japonica cultivar-group), forage grasses,
pearl millet (Pennisetum spp. e.g. P. glaucum), tree species, vegetable species, such as Lycopersicon ssp (e.g. Lyco-
persicon esculentum), potato (Solanum tuberosum, other Solanum species), eggplant (Solanum melongena), peppers
(Capsicum annuum, Capsicum frutescens), pea, bean (e.g. Phaseolus species), fleshy fruit (grapes, peaches, plums,
strawberry, mango), ornamental species (e.g. Rose, Petunia, Chrysanthemum, Lily, Gerbera species), woody trees (e.g.
species of Populus, Salix, Quercus, Eucalyptus), fibre species e.g. flax (Linum usitatissimum) and hemp (Cannabis
saliva).
[0053] A "crop plant" refers herein to a plant species which is cultivated and bred by humans for specific purposes. A
crop plant may be cultivated for food purposes (e.g. field crops), or for ornamental purposes (e.g. production of flowers
for cutting, grasses for lawns, etc.). A crop plant as defined herein also includes plants from which non-food products
are harvested, such as oil for fuel, plastic polymers, pharmaceutical products, cork and the like.
[0054] The construction of chimeric genes and vectors for, preferably stable, introduction of HRD protein encoding
nucleic acid sequences into the genome of host cells is generally known in the art. To generate a chimeric gene the
nucleic acid sequence encoding a HRD protein (or e.g. a HRD-GR domain fusion protein) is operably linked to a promoter













sequence, suitable for expression in the host cells, using standard molecular biology techniques. The promoter sequence
may already be present in a vector so that the HRD nucleic sequence is simply inserted into the vector downstream of
the promoter sequence. The vector is then used to transform the host cells and the chimeric gene is inserted in the
nuclear genome or into the plastid, mitochondrial or chloroplast genome and expressed there using a suitable promoter
(e. g., Mc Bride et al., 1995 Bio/Technology 13, 362; US 5,693, 507). In one embodiment a chimeric gene comprises a
suitable promoter for expression in plant cells or microbial cells (e.g. bacteria), operably linked thereto a nucleic acid
sequence encoding a HRD protein or fusion protein used in the invention, optionally followed by a 3’ nontranslated
nucleic acid sequence.
[0055] The HRD nucleic acid sequence, preferably the HRD chimeric gene, encoding a functional HRD protein (or in
certain embodiments a functional HRD-GR domain fusion protein), can be stably inserted in a conventional manner into
the nuclear genome of a single plant cell, and the so-transformed plant cell can be used in a conventional manner to
produce a transformed plant that has an altered phenotype due to the presence of the HRD protein in certain cells at a
certain time. In this regard, a T-DNA vector, comprising a nucleic acid sequence encoding a HRD protein, in Agrobacterium
tumefaciens can be used to transform the plant cell, and thereafter, a transformed plant can be regenerated from the
transformed plant cell using the procedures described, for Example, in EP 0116718, EP 0270822, PCT publication
WO84/02913 and published European Patent application EP 0242246 and in Gould et al. (1991, Plant Physiol.
95,426-434). The construction of a T-DNA vector for Agrobacterium mediated plant transformation is well known in the
art. The T-DNA vector may be either a binary vector as described in EP 0120561 and EP 0120515 or a co-integrate
vector which can integrate into the Agrobacterium Ti-plasmid by homologous recombination, as described in EP 0116718.
[0056] Preferred T-DNA vectors each contain a promoter operably linked to HRD encoding nucleic acid sequence
between T-DNA border sequences., or at least located to the left of the right border sequence. Border sequences are
described in Gielen et al. (1984, EMBO J 3,835-845). Of course, other types of vectors can be used to transform the
plant cell, using procedures such as direct gene transfer (as described, for example in EP 0223247), pollen mediated
transformation (as described, for example in EP 0270356 and WO85/01856), protoplast transformation as, for example,
described in US 4,684, 611, plant RNA virus- mediated transformation (as described, for example in EP 0067553 and
US 4,407, 956), liposome-mediated transformation (as described, for example in US 4,536, 475), and other methods
such as those described methods for transforming certain lines of corn (e. g., US 6,140, 553; Fromm et al., 1990, Bio/
Technology 8, 833-839; Gordon-Kamm et al., 1990, The Plant Cell 2, 603-618) and rice (Shimamoto et al., 1989, Nature
338, 274-276; Datta et al. 1990, Bio/Technology 8, 736-740) and the method for transforming monocots generally (PCT
publication WO92/09696). For cotton transformation see also WO 00/71733, and for rice’ transformation see also the
methods described in WO92/09696, WO94/00977 and WO95/06722. For sorghum transformation see e.g. Jeoung JM
et al. 2002, Hereditas 137: 20-8 or Zhao ZY et al. 2000, Plant Mol Biol. 44:789-98). Likewise, selection and regeneration
of transformed plants from transformed cells is well known in the art. Obviously, for different species and even for different
varieties or cultivars of a single species, protocols are specifically adapted for regenerating transformants at high fre-
quency.
[0057] Besides transformation of the nuclear genome, also transformation of the plastid genome, preferably chloroplast
genome, is included in the invention. One advantage of plastid genome transformation is that the risk of spread of the
transgene(s) can be reduced. Plastid genome transformation can be carried out as known in the art, see e.g. Sidorov
VA et al. 1999, Plant J.19: 209-216 or Lutz KA et al. 2004, Plant J. 37(6):906-13.
[0058] The resulting transformed plant can be used in a conventional plant breeding scheme to produce more trans-
formed plants with the same characteristics or to introduce the gene part into other varieties of the same or related plant
species. Seeds, which are obtained from the transformed plants, contain the chimeric HRD gene as a stable genomic
insert. Cells of the transformed plant can be cultured in a conventional manner to produce the HRD protein, which can
be recovered for other use e.g. antibody production.
[0059] The HRD nucleic acid sequence is inserted in a plant cell genome so that the inserted coding sequence is
downstream (i.e. 3’) of, and under the control of, a promoter which can direct the expression in the plant cell. This is
preferably accomplished by inserting the chimeric gene in the plant cell genome, particularly in the nuclear or plastid (e.
g. chloroplast) genome.
[0060] Preferred promoters include: the strong constitutive 35S promoters or enhanced 35S promoters (the "35S
promoters") of the cauliflower mosaic virus (CaMV) of isolates CM 1841 (Gardner et al., 1981, Nucleic Acids Research
9, 2871-2887), CabbB-S (Franck et al., 1980, Cell 21, 285-294) and CabbB-JI (Hull and Howell, 1987, Virology
86,482-493); the 35S promoter described by Odell et al. (1985, Nature 313, 810-812) or in US5164316, promoters from
the ubiquitin family (e.g. the maize ubiquitin promoter of Christensen et al., 1992, Plant Mol. Biol. 18,675-689, EP 0 342
926, see also Cornejo et al. 1993, Plant Mol.Biol. 23, 567-581), the gos2 promoter (de Pater et al., 1992 Plant J. 2,
834-844), the emu promoter (Last et al., 1990, Theor. Appl. Genet. 81,581-588), Arabidopsis actin promoters such as
the promoter described by An et al. (1996, Plant J. 10, 107.), rice actin promoters such as the promoter described by
Zhang et al.(1991, The Plant Cell 3, 1155-1165) and the promoter described in US 5,641,876 or the rice actin 2 promoter
as described in WO070067; promoters of the Cassava vein mosaic virus (WO 97/48819, Verdaguer et al. 1998, Plant













Mol. Biol. 37,1055-1067), the pPLEX series of promoters from Subterranean Clover Stunt Virus (WO 96/06932, partic-
ularly the S7 promoter), a alcohol dehydrogenase promoter, e.g., pAdh1S (GenBank accession numbers X04049,
X00581), and the TR1’ promoter and the TR2’ promoter (the "TR1’promoter" and "TR2’promoter", respectively) which
drive the expression of the 1’ and 2’ genes, respectively, of the T-DNA (Velten et al., 1984, EMBO J 3, 2723-2730), the
Figwort Mosaic Virus promoter described in US6051753 and in EP426641, histone gene promoters, such as the Ph4a748
promoter from Arabidopsis (PMB 8: 179-191), or others.
[0061] Alternatively, a promoter can be utilized which is not constitutive but rather is specific for one or more tissues
or organs of the plant (tissue preferred / tissue specific, including developmentally regulated promoters), for example
leaf preferred, epidermis preferred, root preferred, flower tissue e.g. tapetum or anther preferred, seed preferred, pod
preferred, etc., whereby the HRD gene (including e.g. the HRD-GR fusion protein encoding gene) is expressed only in
cells of the specific tissue(s) or organ(s) and/or only during a certain developmental stage. For example, the HRD gene
(s) can be selectively expressed in the leaves of a plant by placing the coding sequence under the control of a light-
inducible promoter such as the promoter of the ribulose-1, 5-bisphosphate carboxylase small subunit gene of the plant
itself or of another plant, such as pea, as disclosed in US 5,254, 799 or Arabidopsis as disclosed in US5034322. The
choice of the promoter is determined by the phenotype one aims to achieve, as will be described in more detail below.
[0062] To achieve drought tolerance a constitutive, a root specific, stress inducible or pathogen inducible promoter
would be suitable. A suitable abiotic stress inducible promoter would be the rd29A promoter (Kasuga et al 1999).
[0063] For expression in root tissue a promoter preferentially active in roots is described in WO00/29566. Another
promoter for root preferential expression is the ZRP promoter (and modifications thereof) as described in US 5,633, 363.
Another root specific promoter is provided in this embodiment as the BOUNTIFUL promoter (Pereira et al, unpublished).
[0064] Another alternative is to use a promoter whose expression is inducible. Examples of inducible promoters are
wound-inducible promoters, such as the MPI promoter described by Cordera et al. (1994, The Plant Journal 6, 141),
which is induced by wounding (such as caused by insect or physical wounding), or the COMPTII promoter (WO0056897)
or the promoter described in US6031151. Alternatively the promoter may be inducible by a chemical, such as dexam-
ethasone as described by Aoyama and Chua (1997, Plant Journal 11: 605-612) and in US6063985 or by tetracycline
(TOPFREE or TOP 10 promoter, see Gatz, 1997, Annu Rev Plant Physiol Plant Mol Biol. 48: 89-108 and Love et al.
2000, Plant J. 21: 579-88). Other inducible promoters are for example inducible by a change in temperature, such as
the heat shock promoter described in US 5,447, 858, by anaerobic conditions (e.g. the maize ADH1S promoter), by light
(US6455760), by pathogens (e.g. EP759085 or EP309862) or by senescence (SAG12 and SAG13, see US5689042).
Obviously, there are a range of other promoters available.
[0065] The HRD coding sequence (or a chimeric HRD protein encoding sequence) is inserted into the plant genome
so that the coding sequence is upstream (i.e. 5’) of suitable 3’ end transcription regulation signals ("3’end") (i.e. transcript
formation and polyadenylation signals). Polyadenylation and transcript formation signals include those of the CaMV 35S
gene ("3’ 35S"), the nopaline synthase gene ("3’ nos") (Depicker et al., 1982 J. Molec. Appl. Genetics 1, 561-573.), the
octopine synthase gene ("3’ocs") (Gielen et al., 1984, EMBO J 3, 835-845) and the T-DNA gene 7 ("3’ gene 7") (Velten
and Schell, 1985, Nucleic Acids Research 13, 6981-6998), which act as 3’-untranslated DNA sequences in transformed
plant cells, and others.
[0066] Introduction of the T-DNA vector into Agrobacterium can be carried out using known methods, such as elec-
troporation or triparental mating.
[0067] A HRD encoding nucleic acid sequence can optionally be inserted in the plant genome as a hybrid gene
sequence whereby the HRD sequence is linked in-frame to a (US 5,254, 799; Vaeck et al., 1987, Nature 328, 33-37)
gene encoding a selectable or scorable marker, such as for example the neo (or nptII) gene (EP 0 242 236) encoding
kanamycin resistance, so that the plant expresses a fusion protein which is easily detectable.
[0068] Transformation of plant cells can also be used to produce the HRD protein (s) used in the invention in large
amounts in plant cell cultures that are resistant to a number of stresses and can be utilized for production of specific
products in culture. When reference to a transgenic plant cell is made herein, this refers to a plant cell (or also a plant
protoplast) as such in isolation or in tissue culture, or to a plant cell (or protoplast) contained in a plant or in a differentiated
organ or tissue, and both possibilities are specifically included herein. Hence, a reference to a plant cell in the description
or claims is not meant to refer only to isolated cells in culture, but refers to any plant cell, wherever it may be located or
in whatever type of plant tissue or organ it may be present.
[0069] All or part of a HRD nucleic acid sequence, encoding a HRD protein (or a chimeric HRD protein), can also be
used to transform microorganisms, such as bacteria (e.g. Escherichia coli, Pseudomonas, Agrobacterium, Bacillus,
etc.), fungi, viruses, algae or insects. Transformation of bacteria, with all or part of a HRD nucleic acid sequence of this
invention, incorporated in a suitable cloning vehicle, can be carried out in a conventional manner, preferably using
conventional electroporation techniques as described in Maillon et al. (1989, FEMS Microbiol. Letters 60, 205-210.) and
WO 90/06999. For expression in prokaryotic host cell, the codon usage of the nucleic acid sequence may be optimized
accordingly (as described for plants above). Intron sequences should be removed and other adaptations for optimal
expression may be made as known.













[0070] For obtaining enhanced expression in monocot plants such as grass species, e.g. corn or rice, an intron,
preferably a monocot intron, can be added to the chimeric gene. For example the insertion of the intron of the maize
Adh1 gene into the 5’ regulatory region has been shown to enhance expression in maize (Callis et. al., 1987, Genes
Develop. 1: 1183-1200). Likewise, the HSP70 intron, as described in US 5,859, 347, may be used to enhance expression.
The DNA sequence of the HRD nucleic acid sequence can be further changed in a translationally neutral manner, to
modify possibly inhibiting DNA sequences present in the gene part by means of site-directed intron insertion and/or by
introducing changes to the codon usage, e. g., adapting the codon usage to that most preferred by plants, preferably
the specific relevant plant genus, as described above.
[0071] In accordance with one embodiment of this invention, the HRD proteins (or chimeric proteins) are targeted to
intracellular organelles such as plastids, preferably chloroplasts, mitochondria, or are secreted from the cell, potentially
optimizing protein stability and/or expression. Similarly, the protein may be targeted to vacuoles. For this purpose, in
one embodiment of this invention, the chimeric genes used in the invention comprise a coding region encoding a signal
or target peptide, linked to the HRD protein coding region. Particularly preferred peptides to be included in the proteins
used in this invention are the transit peptides for chloroplast or other plastid targeting, especially duplicated transit peptide
regions from plant genes whose gene product is targeted to the plastids, the optimized transit peptide of Capellades et
al. (US 5,635, 618), the transit peptide of ferredoxin-NADP+oxidoreductase from spinach (Oelmuller et al., 1993, Mol.
Gen. Genet. 237,261-272), the transit peptide described in Wong et al. (1992, Plant Molec. Biol. 20, 81-93) and the
targeting peptides in published PCT patent application WO 00/26371. Also preferred are peptides signalling secretion
of a protein linked to such peptide outside the cell, such as the secretion signal of the potato proteinase inhibitor11 (Keil
et al., 1986, Nucl. Acids Res. 14,5641-5650), the secretion signal of the alpha- amylase 3 gene of rice (Sutliff et al.,
1991, Plant Molec. Biol. 16,579-591) and the secretion signal of tobacco PR1 protein (Cornelissen et al., 1986, EMBO
J. 5,37-40). Particularly useful signal peptides include the chloroplast transit peptide (e.g. Van Den Broeck et al., 1985,
Nature 313, 358), or the optimized chloroplast transit peptide of US 5,510, 471 and US 5,635, 618 causing transport of
the protein to the chloroplasts, a secretory signal peptide or a peptide targeting the protein to other plastids, mitochondria,
the ER, or another organelle. Signal sequences for targeting to intracellular organelles or for secretion outside the plant
cell or to the cell wall are found in naturally targeted or secreted proteins, preferably those described by Klösgen et al.
(1989, Mol. Gen. Genet. 217, 155-161), Klösgen and Weil (1991, Mol. Gen. Genet. 225, 297-304), Neuhaus & Rogers
(1998, Plant Mol. Biol. 38, 127-144), Bih et al. (1999, J. Biol. Chem. 274, 22884-22894), Morris et al. (1999, Biochem.
Biophys. Res. Commun. 255, 328-333), Hesse et al. (1989, EMBO J. 8, 2453-2461), Tavladoraki et al. (1998, FEBS
Lett. 426,62-66.), Terashima et al. (1999, Appl. Microbiol. Biotechnol. 52,516-5’23), Park et al. (1997, J.Biol. Chem. 272,
6876-6881), Shcherban et al. (1995, Proc. Natl. Acad. Sci USA 92, 9245-9249).
[0072] To allow secretion of the HRD proteins to the outside of the transformed host cell, an appropriate secretion
signal peptide may be fused to the amino terminal end (N-terminal end) of the HRD protein. Putative signal peptides
can be detected using computer based analysis, using programs such as the program Signal Peptide search (SignalP
VI.1 or 2.0) (Von Heijne, Gunnar, 1986 and Nielsen et al., 1996).
[0073] In one embodiment, several HRD encoding nucleic acid sequences are co-expressed in a single host. A co-
expressing host plant is easily obtained by transforming a plant already expressing HRD protein, or by crossing plants
transformed with different HRD proteins. Alternatively, several HRD protein encoding nucleic acid sequences can be
present on a single transformation vector or be co-transformed at the same time using separate vectors and selecting
transformants comprising both chimeric genes. Similarly, one or more HRD encoding genes may be expressed in a
single plant together with other chimeric genes, for example encoding other proteins which enhance drought tolerance,
such as CBF1, DREB1A, the rice OsDREB genes (Dubouzet et al, 2003, Plant J. 33: 751), the SHINE genes (Aharoni
et al 2004, Plant Cell 16: 2463-80) or others.
[0074] It is understood that the different proteins can be expressed in the same plant, or each can be expressed in a
single plant and then combined in the same plant by crossing the single plants with one another. For example, in hybrid
seed production, each parent plant can express a single protein. Upon crossing the parent plants to produce hybrids,
both proteins are combined in the hybrid plant.
[0075] Preferably, for selection purposes but also for weed control options, the transgenic plants obtained by the
invention are also transformed with a DNA encoding a protein conferring resistance to herbicide, such as a broad-
spectrum herbicide, for example herbicides based on glufosinate ammonium as active ingredient (e.g. Liberty® or
BASTA; resistance is conferred by the PAT or bar gene; see EP 0242236 and EP 0242246) or glyphosate (e.g. RoundUp®;
resistance is conferred by EPSPS genes, see e.g. EP0508909 and EP 0507698). Using herbicide resistance genes (or
other genes conferring a desired phenotype) as the selectable marker further has the advantage that the introduction
of antibiotic resistance genes can be avoided.
[0076] Alternatively, other selectable marker genes may be used, such as antibiotic resistance genes. As it is generally
not accepted to retain antibiotic resistance genes in the transformed host plants, these genes can be removed again
following selection of the transformants. Different technologies exist for removal of transgenes. One method to achieve
removal is by flanking the chimeric gene with lox sites and, following selection, crossing the transformed plant with a













CRE recombinase-expressing plant (see e.g. EP506763B1). Site specific recombination results in excision of the marker
gene. Another site specific recombination systems is the FLP/FRT system described in EP686191 and US5527695.
Site specific recombination systems such as CRE/LOX and FLP/FRT may also be used for gene stacking purposes.
Further, one-component excision systems have been described, see e.g. WO9737012 or WO9500555).
Transformed plant cells/plants/seeds obtained by the invention, and uses of the nucleic acid sequence and proteins 
according to the invention
[0077] In the following part the use of the HRD sequences according to the invention to generate transgenic plant
cells, plants, plant seeds and any derivatives/progeny thereof, with one or more modified phenotypes is described.
A) Plants with enhanced stress tolerance
[0078] A transgenic, stress tolerant plant can be generated by transforming a plant host cell with a nucleic acid
sequence encoding the HRD protein under the control of a suitable promoter, as described above, and regenerating a
transgenic plant from said cell. Preferred promoters are promoters which are induced specifically by stresses (abiotic
and biotic) or following application of chemical compounds. In particular the following promoters are preferred:
Rice PR10 promoter (Hashimoto et al, 2004, Plant Cell Physiol. 45: 550-559)
Arabidopsis AtPLA IIA promoter (Narusaka et al, 2003, Plant Cell Physiol. 44: 1246-52)
Arabidopsis CYP83B1 promoter (Narusaka et al. 2004, PMB 55: 327-342)
Wheat germin gf-2.8 promoter (Berna & Bernier, 1999, PMB 39: 539-549)
"Drought tolerance" or "increased/enhanced drought tolerance" is used herein to refer to an enhanced ability of
transformants (compared to wild type or control transformants) to tolerate a period of drought (water deprivation/
depletion leading to e.g. visible leaf wilting symptoms in control plants) and to recover subsequently, thereby leading
to a reduced overall yield loss, as more plants per m2 survive and/or the yield of the surviving plants is not significantly
reduced. Drought tolerance can be assessed in controlled environments (green house or growth chambers) by
placing at least about 10 transformants per transformation event and at least 10 control plants for various time
periods (ranging from 1-4 weeks or more) into the environment without watering them, until leaf wilting or loss of
turgor is caused on control plants, and subsequently watering the plants again for 1-2 weeks, while their recovery
phenotype is analyzed. Transformants with drought tolerance survive at least 2, 3, 4, 5, 6, 7 days, preferably at least
2-5 days longer without water than control-transformants (e.g. transformed with an empty vector) or wild type plants
do under the same conditions, and which show irreversible tissue damage. In another method of estimating tolerance
the recovery of transformants is at least about 2-5 times higher than that of the control plants (e.g. with 20% control
recovery, 40-100% survival in transformants).
"Disease resistance" or "enhanced disease resistance" is used herein to refer to an enhanced ability of transformants
to display a reduction in disease symptoms compared to wild type or control transformants. The disease resistance
screen is done with a pathogen that shows susceptible reaction on wild type plants. In one embodiment the pathogen
is the fungus Verticillium dahliae, as an example of a non host specific resistance. For the screen in Arabidopsis,
seedlings are grown in the growth chamber at 22-24 °C with 12 hour light, in 10 cm diameter pots containing a
mixture of compost:sand:perlite (2:1:1). At two weeks after germination the seedlings are gently uprooted and dipped
briefly in a saturated suspension of Verticillium culture, and then placed back into the pots with soil covering the
roots. The plants are watered normally after a few days pause and examined at various stages for disease symptoms.
The plants are scored in 5 pot replicates per genotype and the disease scores taken as the frequency of plants that
survive at maturity. The wildtype ecotype Wassilewskija shows no survival in this assay, while disease resistant
genotypes show survival ranging from 20-100%.
[0079] Transformants expressing high levels of the HRD protein are selected by e.g. analysing copy number (Southern
blot analysis), mRNA transcript levels (e.g. RT-PCR using HRD primer pairs or flanking primers) or by analysing the
presence and level of HRD protein in various tissues (e.g. SDS-PAGE; ELISA assays, etc). For regulatory reasons,
preferably single copy transformants are selected and the sequences flanking the site of insertion of the chimeric gene
is analysed, preferably sequenced to characterize the "event". High HRD expressing transgenic events are selected for
further crossing / backcrossing / selfing until a high performing elite event with a stable HRD transgene is obtained.
Generally, HRD gene expression levels and HRD protein levels will correlate with the drought tolerance phenotype. In
one embodiment especially the transgenic seeds derived from such plants are provided, which may be sold as being
"drought tolerant".
[0080] Transformants expressing one or more HRD genes according to the invention may also comprise other trans-
genes, such as other genes conferring drought tolerance or conferring tolerance to other biotic or abiotic stresses. To













obtain such plants with "stacked" transgenes, other transgenes may either be introgressed into the HRD transformants,
or the HRD transformants may be transformed subsequently with one or more other genes, or alternatively several
chimeric genes may be used to transform a plant line or variety. For example, several chimeric genes may be present
on a single vector, or may be present on different vectors which are co-transformed.
[0081] In one embodiment the following genes are combined with one or more HRD genes used in the invention:
Genes encoding other AP2/ERF type transcription factors, preferably ones which have a role in the plant’s response to
environmental stresses, such as for example the CBF1, CBF2, CBF3 and/or CBF4 encoding genes from Arabidopsis
(Jaglo-Ottosen et al 1998, Kasuga et al 1999, supra) or orthologs thereof from other species (Dubouzet et al 2003,
supra), the SHN genes (Aharoni et al, 2004, supra), with insect resistance genes such as Bacillus thuringiensis toxin
genes (encoding insecticidal proteins, such as cry genes, vip genes, etc. see http://www.biols.susx.ac.uk/home/ for a
list of available genes), fungal resistance genes, or other genes.
[0082] The stacked transformants may thus have an even broader environmental stress tolerance, to for example
salinity, cold stress, insect resistance, pathogen resistance, heat stress, water stress, etc.
[0083] It is also possible to introduce or introgress the HRD gene into a plant breeding line which already has a relatively
high drought and/or pathogen tolerance, whereby this tolerance may be due to a different underlying molecular mech-
anism (e.g. root architecture).
B) Non-transgenic plants comprising a modified phenotype
[0084] It is also an embodiment of the invention to use non-transgenic methods, e.g. mutagenesis systems such as
TILLING (Targeting Induced Local Lesions IN Genomics; McCallum et al., 2000, Nat Biotech 18:455, and McCallum et
al. 2000, Plant Physiol. 123, 439-442 ) and selection to generate plant lines which produce higher levels of one or more
HRD proteins according to the invention. Without limiting the scope of the invention, it is believed that such plants could
comprise point/deletion mutations in the promoter that are binding sites for repressor proteins that would make the host
HRD gene constitutive or higher in expression. Preferably HRD protein levels in the mutant or parts of the mutant are
at least about 2, 5, 10, 15% or more increased in the mutant compared to non-mutant plants. TILLING uses traditional
chemical mutagenesis (e.g. EMS mutagenesis) followed by high-throughput screening for mutations (e.g. using Cel 1
cleavage of mutant-wildtype DNA heteroduplexes and detection using a sequencing gel system), see e.g. Henikoff et
al. Plant Physiology Preview May 21, 2004. Thus, non-transgenic plants, seeds and tissues comprising an enhanced
HRD gene expression in one or more tissues and comprising one or more of the HRD phenotypes according to the
invention (e.g. enhanced drought tolerance, enhanced disease resistance, etc., all as described above) and methods
for generating and identifying such plants is encompassed herein.
[0085] The method comprises in one embodiment the steps of mutagenizing plant seeds (e.g. EMS mutagenesis),
pooling of plant individuals or DNA, PCR amplification of a region of interest, heteroduplex formation and high-throughput
detection, identification of the mutant plant, sequencing of the mutant PCR product. It is understood that other mutagenesis
and selection methods may equally be used to generate such mutant plants. Seeds may for example be radiated or
chemically treated and the plants screened for a modified HRD phenotype, such as enhanced drought tolerance.
[0086] In another embodiment of the invention, the plant materials are natural populations of the species or related
species that comprise polymorphisms or variations in DNA sequence at the HRD orthologous coding and/or regulatory
sequence. Mutations at the HRD gene target can be screened for using an ECOTILLING approach (Henikoff et al 2004,
supra). In this method natural polymorphisms in breeding lines or related species are screened for by the above described
TILLING methodology, in which individual or pools of plants are used for PCR amplification of the HRD target, heteroduplex
formation and high-throughput analysis. This can be followed up by selecting of individual plants having the required
mutation that can be used subsequently in a breeding program to incorporate the desired HRD-orthologous allele to
develop the cultivar with desired trait.
[0087] Mutant plants can be distinguished from non-mutants by molecular methods, such as the mutation(s) present
in the DNA, HRD protein levels, HRD RNA levels etc, and by the modified phenotypic characteristics.
[0088] The non-transgenic mutants may be homozygous or heterozygous for the mutation conferring the enhanced
expression of the endogenous HRD gene(s) or for the mutant HRD allele(s).
SEQUENCES
[0089]
SEQ ID NO 1: Arabidopsis thaliana HRD coding sequence
SEQ ID NO 2: Arabidopsis thaliana genomic DNA encoding HRD
SEQ ID NO 3: Arabidopsis thaliana HRD amino acid sequence
SEQ ID NO 4: Glucocorticoid receptor (GR) domain protein













SEQ ID NO 5: coding sequence of GR domain with flanking sequences for cloning
FIGURE LEGENDS
[0090]
Figure 1 - The hrd Mutant and 35S : : HRD Plants Phenotype.
A) Phenotype of young hrd mutant plant showing dark green leaves and reduced stature
B) Cross section of leaf of a hrd mutant compared to wild-type, showing more mesophyll cell layers in hrd mutant.
Figure 2 - The root structure of the hrd mutant, compared to wild-type at 3 weeks after germination, showing more
profuse secondary and tertiary roots closer to the stem attachment or root base that provides an overall fibrous
structure.
Figure 3 - The hrd mutant, expression analysis and HRD protein structure
A) The hrd mutant genomic region showing adjacent tagged genes, annotated as AP2 like and aldolase, with
their promoters located 6 kb and 2.3 kb from the CaMV enhancer tetramer of the I-ATag insert.
B) RT-PCR expression analysis of the two genes, AP2-like and aldolase, adjacent the activation tag insert. The
RNA used was made from rosette leaves of 2 wild-type samples and the hrd mutant. The aldolase gene ex-
pression is unchanged, while the AP2-like gene is overexpressed in the hrd mutant and thus a candidate that
confers the phenotype.
C) HARDY amino acid sequence showing the conserved AP2 domain. The shaded box amino acids are identical
to the AP2 domain, and the amino-acids in bold are similar to the AP2 domain consensus.
Figure 4 - Induction of HRD-GR by DEX displays the hardy mutant phenotype
The HRD-GR transformed lines were compared to wild-type Ws ecotype and the hrd mutant. The genotypes were
grown under short day conditions (8 hours daylight) for 4 weeks to increase leaf number. The genotypes were either
treated with the steroid inducer DEX or untreated. The DEX treated HRD-GR genotype shows the similar dark green
leaf phenotype as the hrd mutant.
Figure 5 - Drought Tolerance Experiment with hrd and wild-type.
Fifteen days old seedlings of wild-type Ws, progeny of hrd mutant line, and a positive control rd29-DREB1A line
(providing drought tolerance; Kasuga et al. 1999, supra) were exposed for a period of 9 to 12 days of dehydration.
Subsequently, seedlings were watered and their appearance after a week (recovery) is presented in the image
(apart from the first row at 9 DOD, in which pictures were taken directly at the end of the dehydration period). DOD,
Days of dehydration.
Figure 6 - Steroid inducible drought tolerance conferred by a HRD-GR fusion
The 35S : : HRD-GR line which showed induction by 10 PM DEX treatment, was tested for drought resistance
compared to the hrd mutant and wild-type Ws ecotype. The seedlings of the three genotypes were treated with DEX
after germination and compared to untreated genotypes in a drought assay. The day the wild-type death occurred
was counted as 1 DAWD (days after wildtype death) and the survival of other genotypes counted in relation to this
day. In the first two rows the wildtype is shown displaying dead plants in all samples, and the number of days the
other genotypes survived beyond this in each treatment are shown as 1-3 DAWD. The HRD-GR after DEX induction
shows clear resistance compared to -DEX treatment, and similar to that as shown by the hrd mutant either + or -
DEX treatment.
Figure 7 - Disease resistance of the hrd mutant compared to the wild type.
The hrd mutant (A) compared to a control plant (B), treated with Verticillium pathogen (labelled +V) and without
Verticillium treatment (-V). The hrd mutant is unaffected by Verticillium, while the control plant shows a susceptible
wilted phenotype.
EXAMPLES
[0091] The following non-limiting Examples describe the use of HRD genes for modifying plant phenotypes. Unless
stated otherwise in the Examples, all recombinant DNA techniques are carried out according to standard protocols as













described in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, Second Edition, Cold Spring Harbor
Laboratory Press, and Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring
Harbor Laboratory Press, NY; and in Volumes 1 and 2 of Ausubel et al. (1994) Current Protocols in Molecular Biology,
Current Protocols, USA. Standard materials and methods for plant molecular work are described in Plant Molecular
Biology Labfax (1993) by R.D.D. Croy, jointly published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific
Publications, UK.
Example 1 - Material and Methods
1.1 Plant Material and Drought Tolerance Experiment
[0092] All plants, including the ’activation tag population (Marsch-Martinez et al., 2002, Plant Physiol. 129: 1544-1556)
and transgenic lines were grown in the greenhouse at around 22°C and were in the Arabidopsis ecotype Wassilewskija
(Ws).
[0093] For the drought experiments the activation tagged mutant hardy was compared with the rd29A-DREB-1A line
(providing drought tolerance; Kasuga et al., 1999), both in the Arabidopsis ecotype Ws. The experiment was conducted
in the greenhouse at 22°C, the plants grown in a soil mixture comprised one part of sand and perlite and two parts of
compost (a mixture made up of 25% clay and 75% turf with EC  1 [nitrogen, phosphorous, and potassium]; Hortimea,
Elst, The Netherlands). Seeds were sown (after three nights at 4°C) at density of six plants per 4-cm pot in a tray with
51 pots (Aracon containers; BetaTech, Gent, Belgium). Nutrients (Hydroagri, Rotterdam, The Netherlands; 2.6 EC) were
supplied 10 days after germination, and at 2 weeks after germination the plants were subjected to drought (for 9, 10,
11, or 12 days) by transferring the pots to dry trays (after drying each pot from outside). Every 2 days in drought, the
plants were moved within the tray to nullify pot position effects. Subsequently, plants were rehydrated and observed for
recovery after 1 week. Experiments comparing drought tolerance between the wild type, DREB1A and hrd plants were
repeated three times during winter and summer season giving short and long day conditions respectively. In addition
drought experiment (with similar growth conditions as described above) with the 35S::HRD-GR fusion containing plants
were conducted using DEX induction as described below.
[0094] The inducing agent 10 PM DEX was applied in three different ways to the different genotypes (35S::HRD-GR,
Ws and hrd) to induce different levels of HRD function: a) DEX applied from the bottom of the pots in a tray, b) sprayed
on the top of the plants and c) both from the bottom of pots and sprayed. DEX was applied on the emergence of the first
two leaves of the plant and was applied on every alternate day until the 14th day after germination. Then the plants were
subjected to drought and rehydrated as described previously and observed for the recovery after 1 week.
1.2 Isolation of Flanking DNA and Sequence Analysis
[0095] DNA was isolated according to Pereira and Aarts (1998, Transposon tagging with the En-I system, Totowa,
NJ, Humana Press), from two leaves or young flower buds, and 10 ng of genomic DNA was used for Thermal Asymmetric
Interlaced-PCR (TAIL PCR) as described by (Marsch-Martinez et al., 2002, supra). A re-PCR was generally performed
before sequencing the amplified fragments, and identifying the insert position in the Arabidopsis genome using a BlastN
algorithm (Altschul et al. 1990, J. Mol. Biol. 215:403-410). Multiple sequence alignments were performed using CLUSTAL
X (Thompson et al. 1997, Nucl. Acid Res. 25, 4876-4882) and DNASTAR (DNASTAR Inc. Madison, WI) while the
GENEDOC (Nicholas et al. 1997, EMBNET News 4, 1-4) and TreeView (Page, 1996, Comp. Applic. Biosci. 12: 357-358)
programs were used for editing the alignment and producing the phylogenetic tree, respectively. Phylogenetic analysis
including bootstrapping was conducted as described by Lucker et al. (2002, Eur. J. Biochem. 269, 3160-3171).
1.3 Generation of Plant Transformation Constructs and Transgenic Arabidopsis
[0096] Fragments encoding the genes or regulatory sequences of interest were amplified using pfu DNA polymerase
from genomic DNA. In these cases fragments were A- tailed and introduced to the pGEM-T Easy vector as described
by the manufacturer (Promega) and subsequently sequenced from both sides before digestion and ligation to the Binary
vector. PCR, restriction digests, plasmid DNA isolation and gel electrophoresis were performed using standard protocols.
[0097] Fragments encompassing the full length coding regions were amplified (using pfu DNA polymerase) from
genomic DNA (for HRD, At2g36450) to generate the overexpression constructs. The genomic DNA used for amplification
was from the Arabidopsis ecotype Columbia, using primers HRDF and HRDR.
[0098] Oligonucleotides:
HRDf (5’- CGGATCCAT’GCAAGGAACCTCCAAAGAC - 3’) SEQ ID NO: 6
HRDr (5’- CGTCGACGGTTTGTTTAACTATCATGG -,3’) SEQ ID NO: 7













[0099] The pair of oligonucleotides introduced BamHI and SalI restriction sites to the amplified fragments at their 5’
and 3’, respectively, which were utilized to ligate the 555bp coding region fragments to the BamHI and SalI sites in the
pNEW1 binary vector (a modified pBI121 binary vector, Nayelli Marsch-Martinez and Andy Pereira, unpublished) in
between a 35S promoter of the cauliflower mosaic virus (CaMV) and a nopaline synthase (NOS) terminator. The resulting
construct over expressed the At2g36450 AP2 trancription factor under the control of the 35S promoter.
[0100] For generating the promoter::GUS constructs, a fragment upstream to the ATG codon of each gene (1 kb of
HRD) was amplified from genomic DNA (ecotype Columbia) using Taq DNA polymerase and oligonucleotides which
introduced XbaI NcoI restriction sites at the 5’ and 3’, respectively. This allowed ligation of the fragments to the XbaI
and NcoI sites in a modified pBinPlus vector (van Engelen et al., 1995, Trans. Res. 4, 288-290) upstream of the β-
glucuronidase (GUS) reporter gene.
[0101] For generating the 35S::HRD-GR constructs, a fragment encompassing the full length coding region of HRD
was amplified (using pfu DNA polymerase) from young leaf genomic DNA of Arabidopsis ecotype Columbia using the
oligonucleotides RP6 and RP6 to amplify the 0.55 kb fragment containing the full length coding region of HRD.
RP6 5’- TTATTTCTAGAATGCAAGGAACCTCCAAAGAC - 3’ SEQ ID NO: 8
RP7 5’- TTATTAGATCTTGGAAAATTCCACAAGTAATCG - 3’ SEQ ID NO: 9
[0102] The pair of oligonucleotides introduced XbaI and BglII restriction sites to the amplified fragments at their 5’ and
3’, respectively, which were utilized for ligation. The 35S::HRD-GR construct was assembled by multipoint ligations, in
which the individual fragments (promoter, HRD gene, GR fragment, terminator) with appropriate compatible cohesive
ends were ligated together to the binary vector in one reaction. A CaMV35S promoter fragment extending from -526 to
the transcription start site, was obtained as a 0.55 kb HindIII-XbaI fragment from a pBS-SK+ derivative of pDH51 (Pietrzak
et al., 1986, Nucl Acid Res 14: 5857-68). A GR fragment was obtained as a 0.85 kb BglII-XhoI fragment from pMTL23
(Seq ID 5, coding for GR protein domain Seq ID 4). A CaMV35S terminator fragment was obtained as a 0.21 kb SalI-
EcoRI fragment from a pBS-SK+ derivative of pDH51 (Pietrzak et al., 1986, supra). The construct was made in the binary
vector pMOG22 (ZENECA-MOGEN, NL) which contains a chimaeric CaMV 35S-hygromycin phosphotransferase-tNos
for selection during transformation.
[0103] The rd29A-DREB1A construct used was similar to that described (Kasuga et al., 1999, Nat. Biotech. 17,
287-291), except that the gene fusion was inserted into pBinPlus (van Engelen et al., 1995, Trans. Res. 4, 288-290).
[0104] The constructs were introduced into the plants using the floral dipping transformation method (Clough and
Bent, 1998, Plant J. 16, 735-743). The seeds were plated on one-half-strength Murashige and Skoog medium (1/2MS;
Murashige and Skoog, 1962, Physiol. Plant. 15, 473-497) and seedlings selected on 50 mg/L kanamycin were subse-
quently transferred to.the greenhouse.
1.4 Gene Expression Analyses
[0105] Total RNA for Reverse Transcriptase-PCR (RT-PCR) was isolated from mature, green, rosette leaves derived
from 4 weeks old hardy activation tag mutant and wild type (ecotype WS) plants using the TrizolReagent as described
by the manufacturer (Invitrogen, Life technologies). Approximately 1 Pg of total RNA was used for DNase I treatment
and cDNA synthesis (using SuperScriptII reverse transcriptase) as described by the supplier (Invitrogen, Carlsbad, CA).
The cDNA was diluted 50 times and used for amplification using specific oligonucleotides for the actin gene to equalize
the concentrations of the cDNA samples.
RACTP1, 5’- GCGGTTTTCCCCAGTGTTGTTG -3’ SEQ ID NO: 10
RACTP2, 5’- TGCCTGGACCTGCTTCATCATACT -3’ SEQ ID NO: 11
[0106] Subsequently the diluted cDNA was utilized to perform a PCR reaction using specific oligonucleotides designed
to amplify the two genes flanking the insertion site. Oligonucleotides HRDf and HRDr were used to amplify the At2g36450
gene, and appropriate primers used for the At2g36460 gene. The reaction conditions for PCR included a denaturing
step of 95°C for 3 min, followed by 35 cycles of 1 min at 95°C, 1 min at 55°C, and 1.5 min at 72°C, ending with an
elongation step of 5 min at 72°C. For the control PCR with actin oligonucleotides, 30 amplification cycles were used.
1.5 GUS Staining and Microscopy
[0107] Tissues from various organs either from soil grown plants or seedlings grown on 1/2MS in vitro were analyzed
for their GUS expression patterns. The GUS solution contained 100Mm sodium phosphate buffer, pH 7.0, 0.5 mg/ml 5-
bromo-4-chloro-3-indolyl β-D glucoronic axid (X-Gluc, Duchefa, The Netherlands), 0.1% Triton, and 0.5 mM each of
potassium ferri/ferrocyanide. Samples were vacuum infiltrated and incubated at 37°C for 16 to 24 h and depleted from













chlorophyll in 70% ethanol. Observation were conducted either under the binocular (WILD M3Z of Heerbrugg Switzerland,
type-S), or with a light microscope (Zeiss) and an RS Photometrics CoolSNAP camera (MediaCybernetics®) was used
to take the digital images, with the corresponding CoolSNAP software.
[0108] For Scanning Electron Microscopy (SEM) samples were glued on a sample holder with conductive carbon
cement (Leit- C, Neubauer Chemikalien, Germany) and subsequently frozen in liquid nitrogen. The samples were trans-
ferred under vacuum to a dedicated cryo-preparation chamber (Oxford cryo-system, CT 1500 HF, Eynsham, UK) onto
a sample stage at -90° C. Cryo-fractures were made at approx - 150°C using a cold (-196°C) scalpel blade. The fractured
samples were freeze dried for 3 min at -90°C in vacuum (3x10-7 Pa) to remove water vapour contamination. After the
sample surface was sputter-coated with 10 nm Platinum it was transferred to the cold sample stage (-190°C) inside the
Cryo-FESEM (JEOL 6300F Field Emission SEM, Japan, Tokyo) and subsequently analyzed with an accelerating voltage
of 5 kV.-Images were digitally recorded (Orion, Belgium).
1.6 Microarray Analysis
[0109] Total RNA was isolated using TRIZOL reagent (Life Technologies, Inc.) using two-four rosette leaves of Ara-
bidopsis according to the manufacturers instruction and purified using RNeasy Minelute Kit (Qiagen, Carlsbad, CA,
USA). RNA amplification was performed using Amino Allyl MessageAmp Kit (Ambion, Austin, TX, USA). Briefly, first
strand cDNA synthesis was carried out by reverse transcription using 3 Pg Total RNA and 1 Pl T7 Oligo(dT) primer. Full
length dsDNA was synthesized with the reaction containing 1 second strand buffer, 4 Pl dNTP mix, 2 PlDNA polymerase,
1 Pl RNase H, followed by incubation for 2 h at 16 °C. The DNA was purified by applying to an equilibrated filter cartridge.
The purified cDNA was concentrated and the volume adjusted to 14 Pl. The anti-sense RNA amplification by T7 in vitro
transcription was achieved in a solution containing 12 Pl of ATP, CTP, GTP Mix (25 mM), 3 Pl of aaUTP Solution (50mM) ,
3 Pl of UTP Solution (50mM), 4 Pl of 10  reaction buffer, 4 Pl of T7 enzyme mix at 37 °C for 8 h. Then the amplified
aRNA was purified by applying to an equilibrated filter cartridge.
[0110] For hybridization we used spotted long oligonucleotide Operon array from University of Arizona comprising
29,000 genes of Arabidopsis (http://www.operon.com/arrays/omad.php). The aRNA samples were coupled to mono-
reactive NHS esters of Cy3 or Cy5 (Amersham Biosciences) for 2 hrs. After dye quenching and purification, the targets
were mixed to 80 Pl hybridization solution containing 2xSSC, 0.06xLiquid Blocking Reagent (Amersham Biosciences),
and 0.04% SDS. After heating to 95 °C for 2 min and then cooled on ice, the mixture was applied to the gap between
the slides and coverslip (Lift-erSlip, Erie Scientific). Slides were incubated in a hybridization chamber for 9 h at 56 °C in
an oven. Slides were washed at RT for 5 min in solutions of 2SSC with 0.5% SDS, 0.5SSC, and 0.05SSC sequentially
and then spin dried for 10 min at 1000 rpm.
[0111] Hybridized slides were scanned with the ScanArray Express HT scanner (Perkin Elmer), which generates Tiff
images of both the Cy3 and Cy5 channels. ScanArray PMT voltage was set from 42 to 50 V depending upon the first
sign of a saturated signal. The scanned images were analyzed with the software program ScanArray Express (Perkin
Elmer). Adaptive circle method was used for quantification and for data normalization the LOWESS method was used.
Signal to background method was chosen for quality measurement using default parameters (lower limit 400 and multiplier
1.70) and the results used to check efficiency of the experiments.
[0112] For further analysis, the data was extracted into Excel spreadsheets and the gene expression values of channel
1 or channel 2 (Cy3 or Cy5) that displayed more than 2x background for the median intensity were selected. In addition
we filtered for significant regulated genes that displayed ratios of the medians that were more than 1.5 or less than 0.66
(Log2 values +/- 0.58). These gene expression lists provided us with a long list of potential regulated genes that were
further used for other comparisons between experimental treatments. In the analysis of specific treatments (e.g. drought)
the genes with expressions values of at least one replication more than 2 fold (Log2 values +/-1) were taken to compare
to other treatments.
Example 2 identification of the hardy Mutant and characteristic phenotype
[0113] By screening a collection of 2000 Arabidopsis transposon activation tag lines (Marsch-Martinez et al., 2002) a
mutant plant was identified with slow growth and dark green leaves. Both rosette and cauline leaves of the mutant
(termed hardy, hrd) had thicker leaves when compared to wild type plants. The mutant was later in flowering and had
reduced seed set. The most striking phenotype was that it was difficult to pull the mature plant from the soil, presumably
due to a strong root structure. The plants seemed very tolerant to changes in the greenhouse conditions thus having
the name hardy. Progeny analysis of the self-pollinated hrd mutant line suggested a dominant mutation (three quarters
of the plants exhibited the hrd phenotype).
[0114] The segregating mutant plants showed difference in their growth pattern and size ranging from medium looking
plants to very small plants. The medium sized plants bolted at the same time as wild type indicating that the flowering
time was not affected much in these plants, whereas in the smaller plants the bolting started almost 5 to 6 days later













compared to the wild type indicating that smaller plants had a later flowering time. However the buds opened much later
in the mutant compared to its wild type. In the medium hrd plants the main stem elongated up to 5 to 6 cm tall and had
more number of secondary stems of about the same height as the main stem. The internode length was reduced in the
stems. The plant looked more bushy and compact. The smaller hrd plants (Figure 1A) had very short main and secondary
stems which did not elongate much due to severe reduction in the internode length. Both medium and short sized hrd
plants set lots of flowers compared to wild type but had a low seed set.
[0115] The leaf structure was analyzed by making a cryofracture SEM of the leaf structure, as described in Example
1.5, revealing much thicker leaf with extra palisade layer compared to wildtype (Figure 1B). This extra layer probably
gives the leaf a deep green phenotype because of the higher density of chlorophyll due to smaller cells and more layers.
[0116] The root phenotype was characterized by growing hrd plants in sand with nutrition and washing off the sand
to reveal the root structure. The root structure was analyzed by counting and measuring: the number and length of the
primary, secondary and tertiary roots (Table 1). The most distinguishing feature of the hrd mutant was a root branching
to secondary and tertiary roots (Table 1), very close to the stem or base of the root, just below the soil (Figure 2). This
produced more longitudinal secondary and tertiary roots at the base of the root compared to the wild type giving rise to
more complex root structure similar like a fibrous root system of monocot plants. Hence, these roots had more surface
area to hold on at the base which increased its anchorage capacity to the soil, making them more resistant to pulling.
This phenotype of increased branching close to the root base is a characteristic that contributes to the stronger root
phenotype of the hrd mutant. The hrd mutant requires higher root pulling force as determined by applying force pulling
the hrd mutant and wild-type plants of about 4-week old. The hrd mutant required between 20-50 % more force required
to pull out from the ground compared to wild-type. Root pulling force has been shown related to root lodging trait, an
important trait in cereals and trees that enables the plants to stand upright and resist lodging (Bruce et al, 2001, J Exp
Biol 52: 459-68; Bailey et al 2002, J Exp Biol 53: 333-340).
Example 3 - An AP2/ERF Transcription Factor gene is responsible for the hrd mutant phenotype
[0117] DNA gel blot analysis showed that hrd contains a single insertion (data not shown). Isolation and sequence
analysis of DNA flanking the insertion site further indicated that the insertion is located in an intergenic region on chro-
mosome 1 (Figure 3A). The location of the 35S enhancer tetramer is between a gene encoding an unknown protein
(4025 base pairs upstream of the promoter) and a gene encoding a member of the plant specific AP2/ERF family of
transcription factors (620 base pairs upstream of the promoter). To examine if these two genes were induced in expression
in hrd compared to wild type, we conducted a Reverse Transcription PCR (RT-PCR) experiment using cDNA isolated
from hrd and wild type leaf tissues (Figure 3B). The results showed that only the AP2/ERF gene AT2g36450 at 6 kb
distance from the 35S enhancer tetramer was induced in the hrd mutant leaves compared to wild type leaves and was
the prime candidate responsible for the phenotype.
[0118] The plant AP2/ERF super-family of transcription factors contains 141 members in Arabidopsis (Alonso et al.,
2003, Science 301, 653-657), and the HRD protein contains the AP2/ERF domain (Figure 3C). Sequence homology
searches and phylogenetic analysis across the entire AP2/ERF family showed that HRD is similar to a number of proteins
in rice (data not shown). The rice and Arabidopsis proteins contain the AP2 domain as well as similar amino acid residues
in the C- terminal.
Example 4 - Transgenic plants overexpressing HRD
[0119] The downstream gene (At2g36450), encoding the AP2/ERF transcription factor, was the primary candidate
responsible for the hrd mutant phenotype. Consequently, the coding region of the gene (termed HRD) was cloned and
constitutively expressed in Arabidopsis under the control of the 35S CaMV promoter. All the transgenic plants raised
(10 individuals) showed a phenotype resembling the original activation tag line, in particular the hrd dark green leaf and
smaller structure of the plant (data not shown). The phenotype of most of the 35S::HRD lines (both primary transformants
and subsequent generations) was more severe compared to the original hrd mutant. In most cases plants were smaller,
and in some cases even dwarfed (3 to 5 cm in size upon maturity) (data not shown).
[0120] The same construct was transformed to tobacco and revealed a smaller dark green leaf phenotype showing
Table 1: Measurements of the roots 1cm from the root base in 3 week old plants
Plant line N=4 Primary roots (No.of 
roots  SD)
Secondary roots 
(No.of roots  SD)
Tertiary roots (No.of 
roots  SD)
Length of root base 
(cm)  SD
WT 1  0.00 1.50  0.58 0.00  0.00 0.55  0.06
hrd 1  0.00 4.25  0.50 9.25  1.26 0.28 .0.05













that the leaf phenotype can be conferred in heterologous plants.
Example 5 - Overexpression of the HRD gene in rice
[0121] A construct was made for rice transformation comprising the HRD coding region under control of the CaMV35S
promoter, in the binary vector pMOG22. Transformants were obtained in rice cultivar Nipponbare using established
Agrobacterium system. The calli and regenerated shoots were selected for resistance to hygromucin at concentration
of 25mg/l.
[0122] After rooting the transformants were transferred to the greenhouse and preliminary phenotypic analysis done.
The selfed progeny were then used to do detailed phenotypic and stress tolerance assays. The rice lines transformed
witch the HRD overexpression construct revealed a root system that was longer with more lateral branches than wild-
type. These are features that have been found to be useful to make rice and other cereals more tolerant to drought (Li
et al, 2005, TAG 110: 1244-52; Bruce et al 2001 supra).
Example 6 - Induction of HRD expression using a glucocorticoid gene fusion
[0123] To induce the expression of the HRD gene in different tissues and developmental stages, we generated trans-
genic lines which express a fusion protein of HRD and the hormone binding domain of the rat glucocorticoid receptor
(GR; under the control of the CaMV35S promoter) (Chang et al, 1987, Nuc Acids Res, 22: 9603). Seeds of 35S::HRD-
GR primary transformants (T1) were sown on plates containing media with or without 10PM dexamethasone (DEX)
hormone. Seedlings sown in media supplemented with DEX showed a clear phenotype as seen in the hrd mutant with
shorter seedlings with deep green leaves (Fig 4).
[0124] To characterize the mechanism of HRD expression conferring different phenotypes, experiments to induce the
HRD-GR fusion using dexamethosone (DEX) induction at different stages of growth and parts of the plant were carried
out. Seedlings and fully grown plants containing the 35S::HRD-GR transgene displayed a wild-type phenotype and no
phenotype like the hrd mutants (Fig 4). Seedlings grown in the greenhouse or growth chamber were treated with DEX
at different times after germination (1 week, 10 days after germination) and either from below by irrigation, or sprayed
from top or both sprayed and irrigated. The early treatment and treatment by spraying and irrigation generated plants
with stronger phenotypes as monitored at the leaf level. The strongest induction was with 10uM DEX, displaying a
phenotype similar to that of the original hrd mutant. The different DEX induced levels of the 35S::HRD-GR transgenic
lines were then tested for phenotype of stress induction as outlined below.
[0125] The 35S::HRD-GR plants, when treated with 10 PM DEX from below by irrigation, gave a mild hrd phenotype
and were bigger than the original hrd mutant. These plants showed slight downward curled, deep green rosette leaves
with an elongated stem, having normal looking cauline leaves and normal flowering time (Fig 4). The size of the rosette
leaves was not much affected. The 35S::HRD-GR plants when treated from the top by spraying DEX gave a similar
phenotype as hrd with small rosette, slightly curled down with deep green colour. However, the main stem elongated
normally up to 7-8 cm tall, and the flowering time ranging from normal to late in some plants. When the 35S::HRD-GR
plants were treated both from the bottom (irrigation) and top by spraying DEX they showed a very strong hrd mutant
phenotype with very small severely curled deep green rosette leaves and were late in flowering.
Example 7 - Spatial and Temporal Expression of the HRD gene
[0126] In order to examine the expression of HRD gene a plant transformation construct was generated, which linked
1.0-kb DNA sequences upstream (as shown in Seq ID 2) of the predicted ATG codon of the gene, to the β-glucuronidase
(GUS) reporter gene. In the Arabidopsis transformants GUS expression was detected in the seed and embryo. This
corresponds with the public microarray data on expression of the HRD gene, suggesting that the gene normally functions
during development of the seed, providing stress tolerance during seed maturation.
Example 8 - Plants Overexpressing HRD show Enhanced Drought Tolerance
[0127] In order to examine to what extent the change in plant surface, as a result from HRD over-expression, affected
its drought tolerance capacity. To do so, 15 day-old seedlings of the original activation tag hrd line, a rd29A-DREB1A
resistant control and wild type (ecotype Wassilewskija) were exposed to a period of 9-12 days of dehydration (Figure
5). Subsequently, seedlings were watered and their recovery monitored for a week. While wild type plants did not recover
from the dehydration treatments longer than 9 days and completely dried out, all seedlings derived from lines expressing
the HRD gene recovered to become greener and stronger.
[0128] The HRD-GR transformants that displayed DEX induction of the hardy associated mutant phenotype of dark
green leaves were used for a drought stress experiment. The genotypes WT (wildtype), mutant hrd, and 35S::HRD-GR













were germinated and either treated or untreated with DEX. The DEX treatment was provided either from bottom by
irrigation, by spraying from to, or both from bottom and sprayed. After 2 weeks of growth, the water was withheld for all
treatments and genotypes for a period of 9-15 days. At each day interval, plants were rewatered to be able to test
recovery. The day of wild-type (WT) death was noted for each treatment, and the survival of other genotypes and
treatments were referred to this date. The Days After Wildtype Death (DAWD) were noted as shown in Table 2. Figure
6 shows the results of this experiment. The HRD-GR induced with DEX displays a drought tolerance phenotype equivalent
to that of the hrd mutant. Comparison of experiments, of DEX treatments from below (irrigation to root), spraying from
above (leaf) and both treatments from below and above, showed the combination of treatments gave the most pronounced
phenotype for drought tolerance as seen for the leaf phenotype.
[0129] Similarly, overexpression of HRD in rice also leads to plants with an increased drought tolerance. Transformants
with a 35S::HRD construct are able to withstand prolonged leaf wilting under water deprivation compared to control
plants, as assessed by recovery following rehydration.
Example 9 -Plants overexpressing HRD show enhanced disease tolerance
[0130] To test for biotic stress resistance of the HRD over-expression lines a screen for Verticillium dahliae resistance
was done, as an example of a non host specific resistance. Seedlings were grown in the growth chamber at 22-24° C
with 12 hour light, in 10 cm diameter pots containing a mixture of.compost:sand:perlite (2:1:1). At two weeks after
germination the seedlings were gently uprooted and dipped briefly in a saturated suspension of Verticilium culture, and
then placed back into the pots with soil covering the roots. The plants were watered normally after a few days pause
and examined at various stages for disease symptoms. The plants were scored in 5 pot replicates per genotype and
the disease scores were taken as the frequency of plants that survived at maturity. The wildtype ecotype Ws showed
no survival in this assay, while potential resistant candidate genotypes showed survival ranging from 20-100%.
[0131] In replicated infection experiments with Verticillium, the hrd mutant displayed high level of resistance displaying
none of the wilt symptoms visible in control susceptible wild-type plants (Fig 7). To confirm the effect of the HRD gene,
the resistance tests were repeated in the recapitulated overexpression lines. No wilt symptoms or evidence of pathogen
was visible at maturity suggesting a complete resistance phenotype.
Example 10 - Microarray analysis of the hrd mutant reveal genes responsible for phenotype
[0132] To understand the mechanism of combined abiotic and biotic stress responses, microarray experiments were
done with the hrd overexpression mutant. In our studies on screening for drought tolerant Arabidopsis genotypes, wild
type ecotype Wassilewskija (WS) displayed death after nine days of withholding water, whereas the overexpressor
rd29A::DREB1A and hrd lines still survived till 12 days of withholding water. For uniform testing of plant material we
used 8 days of water withholding for wild type Ws and harvested leaf sample for RNA isolation, and at the same time
took leaf samples from wild type Ws control, rd29A::DREB1A and hrd that were regularly watered. For each comparison
(wild type control vs overexpressor) we used two biological replications respectively. The wild type control aRNAs were
labeled with Cy3 and the wild type drought or the overexpressor aRNAs were labeled with Cy5 in both biological repli-
cations. A number of replications were also done with dye swap experiments as technical control. The experiments were
carried out as described in Example 1.6.
[0133] In the hrd mutant the microarray experiments reveal 142 induced and 151 repressed genes considering genes
consistent in expression in both replications. The Table 3 below shows a selection of the HRD regulon (Set of co-
regulated genes) with induced/repressed genes more than two-fold compared to wild-type. The induced genes are
shown in red color (or dark shade) and repressed in green color (light shaded).
Table 2
Plant line 1 DAWD 2 DAWD 3 DAWD
WT+ Dex 0.00 0.00 0.00
WT - Dex 0.00 0.00 0.00
hrd +Dex 93.33 92.31 96.55
hrd -Dex 93.10 96.43 83.33
HRD-GR + Dex 83.33 75.00 71.43
HRD-GR - Dex 0.00 0.00 0.00













[0134] The pattern of expression of HRD shares partial resemblance to that of DREB1A, suggesting the regulation of
genes that confer the stress tolerance phenotype. However a large number of genes are specifically differentially regulated
in both HRD and DREB1A overexpressors, as shown for the induced genes in Table 3. The genes specifically induced
in the HRD regulon are a set of 4 TFs, Ca2+ signaling proteins as well as trehalose and galactinol metabolism genes.
The biotic stress related genes are represented by the induced defensin PDF2 genes that have been shown to be
induced by pathogen responses in a jasmonate pathway, and repression of the pathogenesis related PR-5 and Bet v1
genes. The difference in HRD and DREB1A in the genes with altered pattern of expression suggests the different
mechanism of action or function of these two AP2/ERF genes. These results and comparison to published microarray
data indicates that the HRD gene regulates a different set of downstream genes than described before for other AP2/ERF
transcription factors. The different set and pattern of regulated genes confer the specific phenotype of the hrd mutant
and HRD overexpressor lines.
Table 3: Genes upregulated by HRD overexpression compared to DREB1A and Drought
HARDY DREBIA DROUGHT
Name Annotation 129 130 193 195 127 128
At2g42540 cold-regulated protein corl5a LEA 2.62 2.24 4.31 5.83 1.4 2.09
At5g50720 ABA-responsive protein (HVA22e) 2.58 2.18 4.01 6.5 1.53 2.3
At5g43150 expressed protein 2.48 1.05 1.72 1.25 2.02 1.93
At5g52310 desiccation-responsive protein 29A (RD29A) 
/LTI78
2.32 2.1 3.48 5.48 2.42 2.87
At5g15970 stress-responsive protein KIN2 / COR6.6 2.25 2.58 1.08 3.82 2.06 2.2
At2g38530 LTP2: nonspecific lipid transfer protein 2 2.14 1.97 3.82 5.47 0.94 0.87
At3g15210 ethylene-responsive element-binding factor 4 
(ERF4)
1.81 1.56 1.38 0.72 1.26 1.52
At1g78070 WD-40 repeat family protein 1.78 1.12 2.95 3.46 1.06 1.19
At1g20440 dehydrin (Cold-induced COR47 protein) 1.74 1.57 4.19 5.7 1.4 1.49
At1g20450 dehydrin ERD10 (Low-temperature-induced 
protein LTI45)
1.56 1:47 3.52 4.17 0.99 1.39
At5g07010 similar steroid sulfotransferase 3 4.65 4.71 2.51 2.01 -0.14 0
At4g30650 to low and salt responsive protein LTI6A 3.91 4.34 3.11 6.7 -0.29 0.27
At3g47540 temperature chitinase, similar to basic 
endochitinase CHB4
3.59 2.75 1.69 0.65 0.15 0.63
At4g12470 protease inhibitor/seed storage/lipid transfer 
protein (LTP)
3.44 1.29 2.71 4.56 0.06 -0.67
At2g24560 GDSL-motif lipase/hydrolase, similar to family II 
lipase EXL3
3.43 3.7 7 7.39 -0.15 0.23
At5g07000 similar to steroid sulfotransferase 3 3.23 4.1 0.95 1.25 -0.37 0.49
At4g12480 lipid transfer protein (LTP) family protein pEARLI 
1
3.15 1.14 5.66 5.7 1.16 -1.58
At1g30360 early-responsive to dehydration stress protein 
(ERD4)
2.76 2.27 2.77 3.63 -0.36 -0.48
At1g33230 expressed protein 2.53 2.02 3.03 4.76 0.38 0.27
At1g04240 indoleacetic acid-induced protein 3 (IAA3) 2.51 2.12 2.56 2.2 -0.44 -0.62
At3g16400 similar to myrosinase-binding protein, Kelch 
motif
2.47 2.11 2.38 2.28 0.13 1.12
At1g54410 dehydrin family protein 2.47 1.41 1.78 2.96 0.18 0.12
At2g02100 plant defensin-fusion protein (PDF2.2) 2.34 4 3.7 3.86 -1.11 -0.29
At3g09540 pectate lyase family protein S10 family protein 2.34 2.55 1.74 1.87 -0.75 -0.49
At5g08260 serine carboxypeptidase 1.97 2.05 0.99 1.17 -0.4 -0.12
At3g53990 universal stress protein (USP) 1.94 1.31 3.66 3.72 -0.02 -0.08
At3g05880 hydrophobic protein RCI2A/LTI6A 1.87 1.4 2.84 4.04 0.05 0.86
At5g07030 aspartyl protease family protein 1.65 2.1 1.13 2.07 -0.33 -0.19
At1g08570 thioredoxin family protein 1.63 1.44 4.21 4.36 0.67 0.44
At1g24575 expressed protein 1.51 1.19 1.89 1.45 0.5 0.5















At2g28550 AP2 domain-containing transcription factor 
RAP2.7
1.3 1 1.63 0.76 -0.09 -0.06
At2g26580 plant-specific transcription factor YABBY family 1.28 1.7 1.77 2.06 0.19 -0.1
At4g24220 expressed protein induced upon wounding 1.2 1.2 2.03 2.25 0.57 0.45
At5g10860 CBS domain-containing protein 1.2 1 0.88 0.8 0.25 -0.04
At1g27030 expressed protein 4.86 5.09 5.79 5.53 -0.63 -2.36
At2g21660 glycine-rich RNA-binding protein (GRP7) 1.17 1.82 2.79 2.53 -1.82 -1.86
At4g19120 early-responsive to dehydration stress protein 
(ERD3)
1.16 1.37 0.75 1.03 -1.82 -1.01
At5g01600 ferritin I (FER1) 3.42 1.04 1.6 -0.3 1.31 2.58
At5g22630 prephenate dehydratase family protein 2.54 3.59 0.37 0 1.9 1.56
At2g41180 igA-binding protein-related 1.7 1.01 1.18 0.57 0.66 0.96
At2g46690 similar to indole-3-acetic acid induced protein 
ARG7
1.65 1.17 0.22 -0.6 0.73 0.72
At5g41400 zinc finger (C3HC4-type RING finger) family 
protein
1.45 1.13 1.78 0.31 1.5 1.36
Tig54000 myrosinase-associated protein, GDSL-like 
Lipase
1.17 2.56 0 0 1.14 0.63
At2g36450 AP2 domain-containing protein 5.83 5.72 0 -0.3 0.19 -0.5
At2g46970 basic helix-loop-helix (bHLH) protein 2.97 3.48 -0.71 3.99 -0.73 0.31
At1g78450 SOUL heme-binding family protein 2.76 2.65 -0.99 1.01 -0.42 -0.78
At1g15550 gibberellin 3 beta-hydroxylase (GA4) 2.57 2.38 0 0 -0.37 -0.33
At1g60140 trehalose-phosphatase family protein 2.2 1.76 -0.76 1.58 0.41 0.18
At3g04630 expressed protein 2.09 1.95 1.1 -0.2 -0.93 -0.71
At2g02130 plant defensin-fusion protein, (PDF2.3) 1.97 2.23 0.34 2.13 -0.64 -0.51
At3g14210 myrosinase-associated protein 1.76 1.32 -1.28 -0.6 -0.46 -0.9
At3g06035 expressed protein (GPI anchored protein) 1.73 1.09 0.85 0.52 0.19 -0.16
At1g21790 expressed protein 1.69 -1.35 3.17 0 0.28 0.8
At5g44130 fasciclin-like arabinogalactan-protein 1.69 1.33 -0.06 0.25 -0.61 -0.72
At2g36460 fructose-bisphosphate aldolase 1.66 1.56 0.79 0.51 0.06 0.03
At4g30660 Hydrophobic protein RCI2A/LTI6A 1.59 1.16 -0.37 0.89 -0.26 -0.4
At4g33490 nucellin protein 1.55 1.83. -1.13 2.47 -0.1 -0.61
At2g27030 calmodulin-2/3/5 (CAM5)(TCH1) 1.41 1.48 2.19 -0.3 -0.44 -0.44
At3g50970 dehydrin xero2 (XERO2)/LTI30 1.39 1.14 8.89 0 -1.06 2.31
At2g03440 similar to Early nodulin 12B precursor 1.39 1.12 0.23 0.57 -0.19 -0.08
At4g15450 similar to early-responsive to dehydration stress 
ERD7
1.38 1.73 0.77 0 0.77 0.39
At5g06710 homeobox-leucine zipper protein 14 (HAT14) / 
HD-ZIP 14
1.25 1.35 -0.24 0.2 -0.37 -2.41
At5g50335 expressed protein 1.23 1.17 -1.05 -0.4 0.13 -0.54
At2g21010 C2 domain-containing protein 1:21 1.47 0.37 0.53 0.01 0.15
At3g60530 zinc finger (GATA type) family protein 1.19 1 2.05 0 0.48 0.24
At1g09570 phytochrome A (PHYA) 1.12 1.48 -0.32 0.6 0.04 -0.7
At1g73480 hydrolase, similarity to monoglyceride lipase 1.11 1.51 -1.16 2.43 0.78 0.57
At2g28900 mitochondrial import inner membrane 
translocase subunit Timl7
2.69 2.65 0.51 5.71 -1.1 -0:93
At3g56090 similar to ferritin subunit cowpea2 precursor 1.8 1.09 0.5 -2.7 -1.44 -0.69
At5g11420 expressed protein 1.63 1.9 0.49 1.21 -1.4 -1.27
At4g32280 auxin-responsive AUX/IAA family protein 1.38 1.09 0 0 -2.57 -1.52
At2g33370 60S ribosomal protein L23 (RPL23B) 1.3 1.14 0.26 0.68 -1.19 -1.54
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At3g50740 UDP-glucoronosyl/UDP-glucosyl transferase 
family protein
1.17 1.45 1.88 0 -1.55 -1.74
At2g47930 hydroxyproline-rich glycoprotein 1.11 1.34 0.23 0.77 -0.97 -1.91




































<223> Description of Artificial Sequence: Glucocorticoid receptor (GR) domain protein
<400> 4































<223> Description of Artificial Sequence: coding sequence of GR domain with flanking sequences for cloning



















<223> Description of Artificial Sequence: oligonucleotide HRDf
<400> 6






<223> Description of Artificial Sequence: oligonucleotide HRDr
<400> 7






<223> Description of Artificial Sequence: oligonucleotide RP6
<400> 8
ttatttctag aatgcaagga acctccaaag ac 32
<210> 9
<211> 33
















<223> Description of Artificial Sequence: oligonucleotide RP7
<400> 9






<223> Description of Artificial Sequence: oligonucleotide RACTP1
<400> 10






<223> Description of Artificial Sequence: oligonucleotide RACTP2
<400> 11
tgcctggacc tgcttcatca tact 24
Claims
1. Use of a nucleic acid sequence encoding a protein having the sequence of SEQ ID NO: 3 or a protein at least 70
% identical to SEQ ID NO: 3, or an ortholog protein for the generation of transgenic plants having a combination of
two or more of the phenotypes selected from the group consisting of: enhanced drought tolerance, enhanced disease
resistance and enhanced root structure.
2. A method for the generation of transgenic plants having a combination of two or more of the phenotypes selected
from the group consisting of: enhanced drought tolerance, enhanced disease resistance and enhanced root structure,
comprising inserting in the genome of the plant a chimeric gene comprising a transcription regulatory sequence
active in plant cells operably linked to a nucleic acid sequence encoding a protein having the sequence of SEQ ID
NO:3 or a protein at least 70% identical to SEQ ID NO:3, or an ortholog protein.
3. A method according to claim 2, wherein said transcription regulatory sequence is selected from the group consisting
of: a constitutive promoter, an inducible promoter, a tissue-specific promoter and a developmentally regulated
promoter.
4. A method according to claims 2 or 3, wherein said transcription regulatory sequence is a stress inducible promoter.
5. A method according to any of claims 2 to 4, wherein the encoding nucleic acid sequence has the sequence of SEQ
ID NO: 1.
Patentansprüche
1. Verwendung einer Nucleinsäuresequenz, die ein Protein mit der Sequenz der SEQ ID Nr. 3 oder ein wenigstens













zu 70 % mit der SEQ ID Nr. 3 identisches Protein oder ein orthologes Protein kodiert, zur Erzeugung transgener
Pflanzen mit einer Kombination von zwei oder mehreren der Phänotypen, die ausgewählt sind aus der Gruppe
bestehend aus: verbesserter Dürretoleranz, verbesserter Krankheitsresistenz und verbesserter Wurzelstruktur.
2. Verfahren zur Erzeugung transgener Pflanzen mit einer Kombination aus zwei oder mehreren der Phänotypen, die
ausgewählt sind aus der Gruppe bestehend aus: verbesserter Dürretoleranz, verbesserter Krankheitsresistenz und
verbesserter Wurzelstruktur, das das Einfügen eines chimären Gens, das eine Transkriptionsregulationssequenz
umfasst, die in Pflanzenzellen aktiv ist und funktionsfähig mit einer Nucleinsäuresequenz verknüpft ist, die ein Protein
mit der Sequenz der SEQ ID Nr. 3 oder ein wenigstens zu 70 % mit der SEQ ID Nr. 3 identisches Protein oder ein
orthologes Protein kodiert, in das Genom der Pflanze beinhaltet.
3. Verfahren nach Anspruch 2, wobei die genannte Transkriptionsregulationssequenz ausgewählt ist aus der Gruppe
bestehend aus: einem konstitutiven Promotor, einem induzierbaren Promotor, einem gewebespezifischen Promotor
und einem entwicklungsregulierten Promotor.
4. Verfahren nach Anspruch 2 oder 3, wobei die genannte Transkriptionsregulationssequenz ein stressinduzierbarer
Promotor ist.
5. Verfahren nach einem der Ansprüche 2 bis 4, wobei die kodierende Nucleinsäuresequenz die Sequenz der SEQ
ID Nr. 1 hat.
Revendications
1. Utilisation d’une séquence d’acides nucléiques codant pour une protéine ayant la séquence de SÉQ ID No.: 3 ou
pour une protéine présentant une identité d’au moins 70 % avec SÉQ ID No.: 3, ou pour une protéine orthologue,
pour générer des plantes transgéniques présentant une combinaison de deux phénotypes ou plus choisis dans le
groupe constitué par : une tolérance améliorée à la sécheresse, une résistance améliorée à la maladie et une
structure racinaire améliorée.
2. Procédé permettant de générer des plantes transgéniques présentant une combinaison de deux phénotypes ou
plus choisis dans le groupe constitué par : une tolérance améliorée à la sécheresse, une résistance améliorée à la
maladie et une structure racinaire améliorée, comprenant l’insertion dans le génome de la plante d’un gène chimé-
rique comprenant une séquence de régulation de la transcription, active dans les cellules végétales, liée de manière
opérationnelle à une séquence d’acides nucléiques codant pour une protéine ayant la séquence de SÉQ ID No.: 3
ou pour une protéine présentant une identité d’au moins 70 % avec SÉQ ID No.: 3, ou pour une protéine orthologue.
3. Procédé selon la revendication 2, dans lequel ladite séquence de régulation de la transcription est choisie dans le
groupe constitué par : un promoteur constitutif, un promoteur inductible, un promoteur spécifique du tissu et un
promoteur régulé au cours de développement.
4. Procédé selon les revendications 2 ou 3, dans lequel ladite séquence de régulation de la transcription est un
promoteur inductible par le stress.
5. Procédé selon l’une quelconque des revendications 2 à 4, dans lequel la séquence d’acides nucléiques codante a
pour séquence SÉQ ID No.: 1.
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